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ABSTRACT 
The incidence of metabolic disease has risen rapidly in the last half-century leading to both 
individual suffering and a burden to society. The importance of physical activity for metabolic 
health is well known. Furthermore, there is increasing evidence that parental food choice and 
obesity can affect the metabolic health of future generations. Although we do not fully 
understand through which mechanisms these effects are occurring. Further insight into these 
processes can prove to be crucial in the fight against metabolic disease. Therefore, the overall 
aim of this thesis is to study mechanisms through which environmental interventions affect 
metabolic health. 
In study I, we investigate the skeletal muscle transcriptomic response of middle-aged men, 
either healthy or diagnosed with type 2 diabetes, after one bout of aerobic exercise. The two 
groups had a similar response to exercise just after the exercise bout. In contrast, three hours 
after the exercised bout skeletal muscle from diabetic subjects had an increased RNA and 
protein content of inflammatory markers. Thus, we describe that in skeletal muscle from 
subjects with type 2 diabetes there is an exacerbated inflammatory response. Whether this 
response is adaptive or mal-adaptive remains to be determined. 
In study II, we exposed male rats to a high fat diet for 10 weeks before they were bred with 
chow-fed females. Male F1 rats, fed a chow diet, were used to generate the F2 generation. 
Some of the F1 and F2 offspring were further challenged with a high fat diet. When evaluating 
the metabolic health of the offspring, we found that females with a high fat-fed ancestry did 
not gain as much body weight when they were exposed to a high fat diet themselves, but were 
even more glucose intolerant than their cage-mates with chow-fed ancestry. We found Let-7c 
to be a possible epigenetic carrier of the ancestral high fat diet. In conclusion, we provide 
evidence that transgenerational inheritance can cause metabolic phenotype through Let-7c. 
In study III and IV, we evaluated tissue-specific differences in of the transcriptome using 
skeletal muscle and liver from the animals in study II respectively. We used an initial 
transcriptomic approach and investigated the tissues with gene arrays. We found that the 
unfolded protein response was activated, possibly through the ATF-6 branch, in skeletal muscle 
from female rats with high fat fed grandfathers compared to females with a grandfather fed a 
chow diet, when subjugated to a high fat diet themselves. In the liver, we found that a 
grandpaternal high fat diet altered the TNF-α signaling pathway, independent of the offspring’s 
own diet. These two studies show transgenerational inheritance in specific tissues. 
Together, the work in this thesis highlights that effects of diet show transgenerational 
inheritance leading to both whole-body and tissue-specific metabolic changes. On the other 
hand, we show that exercise has a different response in the context of type 2 diabetes. Thus, 
the studies in this theses show how environmental factors can affect your metabolic health both 
indirectly and directly.   
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1 INTRODUCTION 
1.1 ENVIRONMENTAL FACTORS AS REGULATORS OF METABOLIC 
DISORDERS 
The technological advancement of the last century has caused a radical shift in the way people 
are living their lives. Work is generally less physically demanding, caloric intake has increased, 
and spontaneous sporting activity has decreased. This disequilibrium of calories in vs. calories 
out has, in turn caused an increase in unhealthy weight gain accompanied by several 
comorbidities such as cardiovascular and metabolic diseases.  
Previously, metabolic diseases, such as obesity and type 2 diabetes mellitus, have been 
considered a problem mainly for the Western civilization. However, this is no longer the case. 
More people are suffering from overweight and obesity than 
undernutrition and starvation (WHO, 2016). During the last 
decades, the prevalence of obesity has escalated at an 
alarming rate. The most common way of classifying 
overweight and obesity is body mass index (BMI) (Table 1). 
Although BMI has been criticized for being imprecise, 
especially on the individual level, it is a good and easy way 
to identify individuals at risk of developing metabolic 
disease. Unfortunately, the Western lifestyle has been 
exported to developing countries, such as India and China, causing more harm to those 
populations.  
Type 2 diabetes, previously known as adult-onset diabetes, is characterized by insulin 
resistance and has been increasing in conjunction with obesity. To diagnose an individual, a 
glucose tolerance test is performed, were a solution containing 75 grams of glucose is 
consumed in the fasting state. The blood glucose is monitored during the following two hours, 
and if it is > 11.1 mmol/L at the final measuring time-point the individual is diagnosed with 
Type 2 diabetes (Table 2). In just 30 years, 1985 – 2015, there has been more than a 10-fold 
increase of diagnosed individuals and it is estimated to keep on increasing (Smyth and Heron, 
2006; GBD, 2016). The disease is caused both by inherited and lifestyle factors. However, 
since no major change of the human DNA code has occurred in that timeframe, lifestyle factors 
are commonly considered to be the major causes of the increase.          
         Table 2 – Type 2 diabetes and impaired glucose tolerance diagnosis criteria’s.  
 
 
Classification Fasting plasma glucose 2-h plasma glucoseNormal ≤ 6 mmol/L ≤ 7.8 mmol/LImpaired fasting glucose 6.1 - 6.9 mmol/L ≤ 7.8 mmol/LImpaired glucose tolerance 7.0 mmol/L 7.8 - 11.1 mmol/LT2D 7.0 mmol/L ≥ 11.1 mmol/L
Classification BMI (kg/m2)Underweight < 18.5Normal weight 18.5 - 24.9Overweight 25 - 29.9Obese Class I 30 - 34.9Obese Class II 35 - 39.9Obese Class III ≥ 40
Table 1 – BMI classification 
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Exercise has proven effective both in the prevention and treatment of metabolic disease. 
Exercise increases insulin sensitivity, insulin-independent glucose uptake, as well as lipid and 
glucose oxidation (Gabriel and Zierath, 2017). Exercise capacity and general fitness seem to 
be even more vital to overall health than adiposity, as exemplified by the “obesity paradox” 
(Lavie et al., 2015). It is worth noting, that there is ongoing debate regarding whether or not 
there really is such a thing as “healthy obesity” (Fan et al., 2013; Kramer et al., 2013). 
However, it is clear that exercise is beneficial, if not crucial, for a healthy life, and thus 
understanding exercise–mediated mechanisms of health improvement is important.  
Although lifestyle factors are part of the explanation, there is an increasing amount of evidence 
indicating inherited biological factors contribute to the escalating rates of obesity and its 
comorbidities (Lake et al., 1997; Pembrey et al., 2006; Carone et al., 2010). Even more 
interesting is that there is a missing link between the heritability of metabolic disorder and 
associated genes. More than 150 genetic loci have been linked to the development of obesity 
or diabetes though only around 10% of the heritability of type 2 diabetes can be explained, 
using the significant genome-wide association studies identified in humans with European 
ancestry (Bonnefond et al., 2010; McCarthy, 2010). The realization that disease etiology may 
be partially independent of genetic alterations has sparked an increased interest in the field of 
epigenetics. Epigenetics is defined as inheritable changes of a phenotype that is not caused by 
a change in the DNA. Furthermore, epigenetic traits have been suggested to be one of the 
missing pieces that may explain the heritability of the obesity and type 2 diabetes in the current 
epidemic. The work of this thesis focuses on exploring the genetic alterations in skeletal muscle 
due to exercise and the influence of transgenerational epigenetic inheritance on metabolic 
disease.  
1.2 INFLAMMATION AND METABOLIC DISEASE 
There is a strong connection between development of metabolic disease and a dysregulated 
inflammatory response. Chronic low-grade inflammation is a trait of both obesity and type 2 
diabetes (Donath and Shoelson, 2011; Ouchi et al., 2011). In lean healthy individuals, nutrients 
are stored and metabolized in metabolically active tissues such as the liver, adipose, and 
skeletal muscle tissue. However, in obese individuals, adipocytes have been forced to expand 
in size and numbers to cope with the over consumption of calories. At one point, the adipocytes 
are no longer able to store the excess lipids and thereby causing a “spill over” of lipids to other 
compartments in the body, which are less well equipped to story fat. This, in turn, will trigger 
activation of several stress- and inflammatory signaling pathways in the affected tissues and 
cells, sometimes referred to as lipotoxicity (Unger, 1995). Other physiological states, 
potentially caused by over nutrition, which can initiate insulin resistance through inflammation, 
are glucotoxicity, endoplasmic reticulum stress, and oxidative stress (Rossetti et al., 1987; 
Evans et al., 2002). Although, there is still an ongoing debate as to whether metabolic diseases 
cause insulin resistance or if insulin resistance causes metabolic diseases, the link between the 
two is undisputed.  
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1.2.1 Inflammation in different metabolically active tissues  
Adipose tissue is, besides an energy-storage site, an endocrine organ that can affect the whole 
body. Furthermore, in addition to containing adipocytes, it is also the residence of immune 
cells. Macrophages in particular have received attention by the scientific community. Obesity 
is associated with increased immune cell infiltration and the number of macrophages in adipose 
tissue correlates with adipocyte size (Weisberg et al., 2003; Xu et al., 2003). Additionally, 
macrophages in adipose tissue undergo a phenotypic switch in the obese environment, from 
having anti-inflammatory M2 characteristics to becoming pro-inflammatory M1 macrophages 
(Lumeng et al., 2007). The enlarged adipocytes also contribute pro-inflammatory cytokines 
and chemokines (Skurk et al., 2007). Together, all of this adds to systemic inflammation and 
the development of metabolic disorders (Esser et al., 2013).  
Unhealthy weight gain leads to lipid accumulation and inflammation in the liver. Nowadays, 
non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of liver disease 
and two thirds of the patients are obese (Bellentani et al., 2004; Vernon et al., 2011). If left 
untreated, the “simple” hepatic steatosis can develop into non-alcoholic steatohepatitis 
(NASH). NASH is characterized by, apart from the lipid accumulation, inflammation and 
fibrosis. It is elicited by several factors such as mitochondrial dysfunction, oxidative stress, and 
pro-inflammatory cytokines (Day and James, 1998). Unlike the adipose tissue, obesity does 
not increase the amount of immune cells in the liver but causes primarily the Kupffer cells to 
be activated (Cai et al., 2005). Weight loss due to lifestyle intervention or bariatric surgery will 
reduce steatosis and the pro-inflammatory state in the liver (Weiner, 2010; Musso et al., 2012), 
further demonstrating the close link between inflammation and metabolic disease. 
One of the major organs affected by obesity and type 2 diabetes is skeletal muscle. The 
associated insulin resistance will greatly reduce insulin-stimulated glucose uptake by the 
muscle cells (DeFronzo, 1988). Despite this, the link between dysregulated metabolism and 
inflammation in skeletal muscle is less investigated than other tissues such as liver and adipose. 
Just as in adipose tissue, there is evidence that obesity can increase immune cell infiltration 
into skeletal muscle and that they appear to exhibit a pro-inflammatory phenotype (Fink et al., 
2014; Khan et al., 2015). This is also observed in type 2 diabetes patients (Fink et al., 2013). 
Local inflammation in skeletal muscle can impair insulin signaling and thereby decrease insulin 
sensitivity through autocrine and paracrine effects (Austin et al., 2008; Patsouris et al., 2014). 
The interaction between inflammation and metabolism in skeletal muscle is a relatively 
unexplored field that is both interesting and has the potential to be fruitful in the search for 
therapeutic targets against metabolic disease. 
1.2.2 Molecular interactions between inflammatory and metabolic pathways 
On a molecular level, the NF-κB and JAK/STAT pathways are of interest when exploring the 
interplay between dysregulated metabolism and inflammation (Figure 1). One of the main 
activators of NF-κB is TNF-α, though it can also be activated by several growth factors 
(Lowenthal et al., 1989; Biswas et al., 2000; Bhat-Nakshatri et al., 2002). After binding to its 
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receptor, TNF-α activates a cascade that will lead to activation of IκB kinase (IKK), which will 
ultimately free NF-κB from IκB, thereby leaving NF-κB free to migrate into the nucleus and 
act as a transcription factor. Furthermore, activation of the NF-κB pathway can lead to insulin 
resistance through IKK or c-Jun N-terminal kinase (JNK) activation (Aguirre et al., 2002; Gao 
et al., 2002; Lee et al., 2003). JNK prevents activation of the insulin receptor (IR) by 
phosphorylating inhibitory sites of the insulin receptor substrate (IRS) (Aguirre et al., 2000; 
Aguirre et al., 2002). The JAK/STAT pathway is primarily activated by interferons or 
cytokines such as IL-6. Although it is still unclear exactly through which mechanism the 
JAK/STAT pathway can also induce insulin resistance, it is suggested that this occurs through 
an increased abundance of SOCS1/3. Activation of JAKs results in increasing the 
phosphorylation of STAT1 and STAT3, which will lead to increased transcription and 
translation of SOCS1/3 that can interrupt the interaction of IR and IRS (Grzelkowska-
Kowalczyk and Wieteska-Skrzeczynska, 2009; Gorina et al., 2011; Tanti et al., 2012; Mashili 
et al., 2013) 
 
Figure 1 - Schematic illustration of inflammatory pathway connected to metabolism. Abbreviations used in the  Figure: AP-1 (Activator protein), IFN-γ (Interferon gamma), IKK (IκB kinase), IL-6 (Interleukin 6) IRS (Insulin receptor substrate), JAK (Janus kinase), JNK (c-Jun N-terminal kinase), NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells), SOCS1/3 (Suppressor of cytokine signaling 1/3), STAT1/3 (Signal transducer and activator of transcription 1/3) and TNF-α (Tumor necrosis factor alpha) 
 
Another interaction site between metabolism and inflammation is the endoplasmic reticulum 
(ER) and the unfolded protein response (UPR) pathway (Figure 2). The ER is the key location 
for protein folding. If stressed by the accumulation of unfolded proteins the ER will initiate the 
UPR. Several symptoms of dysregulated metabolism such as lipotoxicity, hyperglycemia, and 
reactive oxygen species can cause ER stress (Shimoke et al., 2003; Cnop et al., 2010). The 
UPR consists of three branches: IRE-1, ATF6 and PERK. IRE-1 acts by initiating splicing of 
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XBP-1, turning it into an important transcription factor and thereby upregulating UPR genes 
needed to deal with the ER stress. ATF6 is located in the ER membrane and when it senses 
increased ER stress it is transported to the Golgi apparatus where it is cleaved and further 
migrates to the nucleus where it promotes transcription of ER chaperones (Wang et al., 2000). 
PERK activation will cause eIF2α to be phosphorylated, thereby reducing protein synthesis and 
subsequently reduces the ER stress (Wang et al., 2000). PERK can also cause a transcriptional 
response by activating ATF4 and, further downstream in the cascade, CHOP (Hotamisligil, 
2010). Just as with other of inflammatory responses, the UPR is a crucial system when dealing 
with short-term stressors, but is harmful if constitutively activated.  
 
 
Figure 2 – Schematic illustration of the unfolded protein response signaling pathway. Abbreviations used in the  Figure: AP-1 (Activator protein), ATF4 (Activating transcription factor 4), ATF6 (Activating transcription factor 6), cATF6 (cleaved activating transcription factor 6), CHOP (C/EBP homologous protein), eIF2α (Eukaryotic translation initiation factor 2 subunit 1), ER (endoplasmic reticulum), IRE-1 (inositol-requiring enzyme 1 α), JNK (c-Jun N-terminal kinase), NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells), PERK (protein kinase R (PKR)-like endoplasmic reticulum kinase), TRAF2 (TNF receptor-associated factor 2), XBP-1s (X-box binding protein 1 spliced) and XBP-1u (X-box binding protein 1 unspliced). 
1.2.3 Inflammatory mediators 
There are a number of acute phase proteins, cytokines and chemokines, which are mediators of 
either pro-inflammatory or anti-inflammatory responses. Proteins that can act as inflammatory 
mediators and are included in the scientific papers of the thesis are summarized in Table 3 with 
a short description of their function and whether or not their circulatory levels are altered by 
obesity or diabetes in humans.  
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Table 3 – Table of inflammatory mediators included work of this thesis. Type 2 diabetes (T2D) 
Name Symbol Main function Obesity T2D References 
Acute phase proteins      
Alpha 2-Macroglobulin A2M 
Protease inhibitor, can bind and carry inflammatory cytokines 
na ↑ (James et al., 1980; Rehman et al., 2013) 
C-reactive protein CRP Role in innate immunity ↑ ↑ (Visser et al., 1999; Duncan et al., 2003) 
Haptoglobin Hp Binding free plasma hemoglobin ↑ ↑ (McMillan, 1989; Chiellini et al., 2004)  
serum amyloid A component SAA 
Recruitment of immune cells to inflammatory sites ↑ ↑ (Pickup et al., 1997; Yang et al., 2006) 
serum amyloid P component SAP Mediated phagocytosis  na na (Wright et al., 1983) 
Chemokines      
Chemokine (C-C motif) ligand 2 CCL2 
Chemoattracts monocytes & macrophages ↑ ↑ (Kim et al., 2006; Liu et al., 2012) Chemokine (C-C motif) ligand 21 CCL21 
Adhesion of naive T cells na ↑ (Gunn et al., 1998; Van Dyke et al., 2017) 
Chemokine (C-X3-C motif) ligand 1 CX3CL1 
Chemoattracts T cells and monocytes ↑ ↑ (Shah et al., 2011) Chemokine (C-X-C motif) ligand 1 CXCL1 
Chemoattracts neutrophil activity ↑ ↑ (Maury et al., 2010; Sajadi et al., 2013) 
Chemokine (C-X-C motif) ligand 9 CXCL9 
Chemoattracts T cells na na (Muller et al., 2010) 
Chemokine (C-X-C motif) ligand 10 CXCL10 
Chemoattracts T cells and monocytes ↑ ↑ 
(Dufour et al., 2002; Van Dyke et al., 2017; Hueso et al., 2018)  
C-X-C motif chemokine 12 CXCL12 Chemoattracts lymphocytes na na (Bleul et al., 1996) 
C-X-C motif chemokine 16 CXCL16 Chemoattracts T cells ↑ = (Matloubian et al., 2000; Zhao et al., 2014; Lopes et al., 2018)  
C-X-C motif ligand 2 CXCL2 
Chemoattracts polymorphonuclear leukocytes ↑ na (Wolpe et al., 1989; Rouault et al., 2013) 
Cytokines      
Interleukin 1 alpha IL-1α Induces NFκB pathway ↑ = (Di Renzo et al., 2007; Donath and Shoelson, 2011; Ballak et al., 2015)  
Interleukin 1 beta IL-1β Induces NFκB pathway ↑ ↑ (Spranger et al., 2003; Um et al., 2004; Ballak et al., 2015) 
Interleukin 2  IL-2 Induces regulatory T cell proliferation ↓ ↓ (Liao et al., 2011; Vargas et al., 2016) 
Interleukin 4 IL-4 
T-cell activation and promotes a M2 phenotype of macrophages 
↑ na (Egawa et al., 2013; El-Wakkad et al., 2013)  
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Interleukin 5 IL-5 Induces B cell growth ↑ na (Takatsu et al., 2009; El-Wakkad et al., 2013)  
Interleukin 6 IL-6 Activates a pro- or anti-inflammatory response  ↑ ↑ 
(Roytblat et al., 2000; Pradhan et al., 2001) 
Interleukin 10 IL-10 Anti-inflammatory action, can block NF-κB activity ↓ na (Esposito et al., 2003) 
Interleukin 12 IL-12 Stimulates TNF-α and INF-γ production   ↑ ↑ 
(Tripp et al., 1993; Mishra et al., 2011; Suarez-Alvarez et al., 2013) 
Interleukin 13 IL-13 
Induces anti-inflammatory pathway, similar to IL4 
na na (Zurawski and de Vries, 1994) 
Interleukin-16 IL-16 Chemoattrats CD4+ immune cells na na (Cruikshank et al., 2000) Granulocyte-macrophage colony-stimulating factor 
GM-CSF 
Stimulates monocyte and granulocyte production 
na na (Burgess and Metcalf, 1980) 
Interferon gamma IFN-γ Activation of macrophages na = (Dalton et al., 1993; Balducci et al., 2010)  
Tumor necrosis factor alpha TNF-α 
Promotion of inflammation (via NFκB pathway) ↑ ↑ (Miyazaki et al., 2003; Park et al., 2005) 
 
1.3 EXERCISE 
Already the Greeks of the ancient world knew about the beneficial effects of physical activity 
and exercise. The main differences regarding the definitions of physical activity and exercise 
is that exercise is a structured, repetitive, planned, intentional movement that is intended to 
maintain or increase physical fitness. Modern technology has made it possible to replace the 
physical workforce that was previously needed for the majority of human history. As a result, 
there has been a decrease in the amount of everyday (and spontaneous) physical activity and 
an increase in organized exercise. Consider that a “treadmill” once referred to a mill powered 
by treading men, but now refers to a workout machine. About 24% of the world population is 
now, according to the WHO definition physically inactive (Sallis et al., 2016). What is even 
more alarming is that studies based on questionnaires usually underestimate the level of 
physical inactivity. In an English self-reported study, 39 % of the men and 29 % of the women 
reported that they were meeting the physical activity guidelines. However, when a subset of 
the participants were equipped with accelerometers, it turned out that only 6% and 4%, 
respectively, actually met the requirements (Health and Social Care Information Centre, 2009). 
A similar accelerometer study from the USA found that 86% of the subjects did not meet the 
physical activity criteria and are de facto inactive (Troiano et al., 2008). In conclusion, it is 
possible that the prevalence of inactivity is even higher than reported by the WHO. 
Physical inactivity is a risk factor for a number of chronic diseases such as coronary heart 
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disease, accelerated biological aging/premature death, sarcopenia, metabolic syndrome, 
obesity, insulin resistance, gestational diabetes, type 2 diabetes, peripheral artery disease, 
hypertension, stroke, arterial dyslipidemia, congestive heart failure, endothelial dysfunction, 
depression and anxiety, osteoporosis, rheumatoid arthritis, colon cancer, breast cancer, and 
endometrial cancer (Booth et al., 2012). The onset of type 2 diabetes can be prevented, or at 
least delayed, by lifestyle interventions that include physical activity/exercise (Tuomilehto et 
al., 2001). For people with type 2 diabetes, exercise improves overall quality of life, blood 
glucose levels, blood pressure, body weight, and lipid levels (Gregg et al., 2012; Wing et al., 
2013; Espeland et al., 2014).  
Besides transforming chemical energy into mechanical energy during exercise, skeletal muscle 
is also the tissue that takes up a majority of the glucose postprandially. Because of this, it has 
been the focus for a majority of mechanistic exercise adaptation studies. The primary glucose 
transporter in skeletal muscle is glucose transporter 4 (GLUT4). Under resting conditions, or 
in the fasted state, GLUT4 is mainly located in the cytoplasm and is thereby not able to 
transport glucose through the cell membrane. However, both insulin and exercise can trigger 
GLUT4 translocation to the cell surface (Figure 3). Increased insulin levels in the plasma will 
activate the insulin receptor (IR), which in turn activates the IRS. At the end of the signaling 
pathway TBC1 domain family member 4 (TBC1D4), will trigger the GLUT4 vesicles to 
translocate to the cell membrane and thereby increasing glucose uptake into the cell. This is 
known as insulin-dependent glucose uptake.  Muscle contraction/exercise is on the other hand 
known as insulin-independent stimulator of glucose uptake. Exercise triggered translocation of 
GLUT4 occurs mainly through 1) Ca2+/calmodulin-dependent protein kinase II (CaMKII), 
which is activated by the increased amounts of Ca2+. 2) Through the increased amounts of nitric 
oxide by nitric oxide synthase (NOS). 3) By an increased AMP:ATP ratio caused by the high 
energy demand from the exercise, which increases 5' AMP-activated protein kinase (AMPK) 
activity, that will in turn activate TBC1 domain family member 1 (TBC1D1) and TBC1D4 
(Ojuka and Goyaram, 2014). 
Since GLUT4 translocation can be activated though these two different mechanisms, exercise 
is a good alternative to increase glucose uptake in individual that have developed insulin 
resistance. In addition to the acute effect of exercise on GLUT4 translocation, chronic exercise 
increases the amount and activity of mitochondria, and leads to metabolic flexibility (Meex et 
al., 2010; Higashida et al., 2011). Furthermore, exercise training can increase the amount of 
GLUT4 protein in skeletal muscle of type 2 diabetes subjects (Little et al., 2011). It is still not 
fully understood through which mechanisms physical activity and exercise make skeletal 
muscle more insulin sensitive. Learning this can prove crucial in the fight against metabolic 
disease. In summary, exercise is not only favorable for a healthy life, but failing to meet the 
recommendations is outright detrimental.   
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Figure 3 – Schematic illustration of glucose transtporter 4 (GLUT4) translocation in skeletal muscle. AKT (Protein kinase B), AMPK (5' AMP-activated protein kinase), CaMKII  (Ca2+/calmodulin-dependent protein kinase II), GLUT4 (glucose transporter 4), IRS (Insulin receptor substrate), NOS (nitric oxide synthase), PI3K (Phosphatidylinositol-4,5-bisphosphate 3-kinase), TBC1D1 (TBC1 domain family member 1) and TBC1D4 (TBC1 domain family member 4). 
 
1.3.1 Exercise and inflammation 
Exercise is dependent on muscular contractions and because of this, skeletal muscle has been 
the tissue in focus for most types of exercise studies, inflammation included. Exercise will 
increase the amount of reactive oxygen species that in turn will trigger inflammatory signaling 
pathways such as NF-κB. Previously, this has been viewed as a deleterious process that should 
be avoided. However, non-steroidal anti-inflammatory drugs will inhibit the protein synthesis 
after exercise and blunt the exercise induced increase of satellite cells (Trappe et al., 2002; 
Mackey et al., 2007).  This demonstrates how pro-inflammatory processes are crucial for a 
normal adaptive exercise response. Another part of the inflammatory response after exercise is 
the accumulation and activation of leukocytes in skeletal muscle (Peake et al., 2005; Neubauer 
et al., 2008). The inflammatory response can be divided into two different phases, the early 
and the late phase. In the early phase pro-inflammatory M1 macrophages, are more pronounced 
and are in charge of “cleaning up” cell debris before switching into more anti-inflammatory 
M2 macrophages that promote muscle regeneration (Arnold et al., 2007; Varga et al., 2016). 
Apart from being vital for tissue remodeling, leukocytes are important for maintaining normal 
glucose uptake in skeletal muscle and are able to enhance muscle performance through GLUT4 
translocation (Tsuchiya et al., 2018). Even though inflammation is part of the exercise 
response, it is still not clear if is dysregulated in people suffering from metabolic diseases.   
On a whole-body level, exercise can reduce markers of chronic low-grade inflammation that 
are associated with type 2 diabetes (King et al., 2003; Wang et al., 2013; Hayashino et al., 
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2014). This occurs through both direct and indirect actions. One direct effect of exercise is 
reduce the accumulation of inflammatory-prone visceral fat (Vissers et al., 2013). Furthermore, 
exercise promotes the secretion of anti-inflammatory cytokines into the blood.  Whether IL-6 
has a role as a pro- or anti-inflammatory cytokine is still debated. Obese people have increased 
levels of circulating IL-6, suggesting that it is more of a pro-inflammatory cytokine. However, 
IL-6 is also increased by exercise and it has been shown to inhibit TNF-α production (Schindler 
et al., 1990; Northoff and Berg, 1991). Overall, chronic exercise has a proven anti-
inflammatory effect. However, an acute pro-inflammatory response is necessary for the 
beneficial training adaption to occur. Together this highlights the complex interaction between 
exercise and inflammation.  
1.4 EPIGENETIC REGULATION 
After the complete human genome sequenced, the expectations were that most, if not all, 
diseases would be traced to genetic causes. Thereby simplifying disease preventions and drug 
development. However, this way of thinking completely ignored the plasticity and rapid 
response of the genome to environmental stimuli that are often observed in biology. Since many 
diseases cannot be explained by alterations in the genetic code, there has been a paradigm shift 
that also takes into account epigenetic factors. The interplay between the environment and 
genome is thereby taken into account (Figure 4).  The main epigenetic mechanisms DNA 
methylation, histone modification, and non-coding RNAs, will be briefly described in this 
section, (Figure 5). 
 
 Figure 4 - Epigenetic and genetic cascade of events involved in development of phenotypes. 
1.4.1 DNA methylation 
DNA methylation was the first discovered and is the currently most investigated epigenetic 
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factor (Holliday and Pugh, 1975). In mammals, it is the cytosine base that is primarily 
methylated at the C5 position, but there has also been some observations suggesting that other 
DNA bases could be methylated (Barres et al., 2009; Ziller et al., 2011; Kulis et al., 2015). In 
general, DNA methylation leads to repression or silencing of gene transcription, where the 
inactivation of one of the X-chromosomes in females is a classic example (Riggs, 1975). One 
of the mechanisms behind the repression/silencing is that methylation can sterically block the 
binding of transcription factors to the DNA. Although, DNA methylation is stable in somatic 
cells, there have been several studies demonstrating that the methylation and demethylation 
process are much more dynamic than previously thought (Shen et al., 2013). Environmental 
factors can change the methylome of twins (Fraga et al., 2005). Furthermore, exercise and 
weight loss can alter DNA methylation levels (Barres et al., 2012; Moleres et al., 2013). This 
data strongly suggests DNA methylation plays a role in mediating environmental changes in 
the regulation of metabolism. 
1.4.2 Histone modification 
The DNA is wrapped around protein structures referred to as histones, which can regulate gene 
expression by making the DNA more or less accessible for transcription. Histones can be 
modified at their tails in more than 60 ways. Although, it is possible to reduce and simplify this 
number to 10-15 patterns with specific genetic regulation (Tan et al., 2011; Ko and Susztak, 
2013).  Histones are modified by adding or removing methylation groups, acetylation, 
phosphorylation, sumoylation and ubiquitination by several different enzymes (Biel et al., 
2005). Unlike DNA methylation, that in general is a more stable/long term repressor of gene 
transcription, histone modifications are relatively flexible and short-term in their character 
(Reik, 2007).   
1.4.3 Non-coding RNA 
Non-coding RNA is transcribed from DNA, but not translated into a protein. Large regions of 
the genome that do not code for protein have previously been described as “junk-DNA”. 
However, several of these transcripts have been subsequently revealed to have a regulatory 
function.  
Small non-coding RNAs (sncRNA) is a group of RNAs that are shorter in length than 200 
nucleotides, which include a number of different RNA classes such as micoRNAs (miRNAs), 
short interfering (siRNAs) and piwi-interacting RNAs (piRNAs). miRNAs were first 
discovered in the early 1990’s and contain around 22 nucleotides (Lee et al., 1993; Wightman 
et al., 1993). However, it was not until the early 2000’s their functions were better understood 
(Reinhart et al., 2000; Lee and Ambros, 2001). miRNAs function by silencing mRNA by first 
base-pairing to the transcript, which will either cleave the mRNA, causing a less efficient 
translation in the ribosome, or by shortening the poly(A) tail of the mRNA and thereby 
destabilizing it. Since the role of miRNAs was discovered, numerous studies have been 
performed linking miRNAs to several diseases such as cancer, type 2 diabetes and obesity 
(Ortega et al., 2010; Kantharidis et al., 2011; Honardoost et al., 2014).  piRNAs are also able 
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to modulate gene expression by forming RNA-protein complexes and particularly targeting 
transposons. In mammals, the piRNAs are most abundant in testes and ovaries and have been 
shown to be crucial for spermatogenesis (Carmell et al., 2007). 
 
 
 
Figure 5 - Schematic of Epigenetic Mechanisms. A) DNA methylation of CpGs.  B) Chromatin alteration by histone tail modifications. C) mRNA silencing by miRNA. 
 
1.5 NON-MENDELIAN INHERITANCE 
The idea that environmental information can be transferred from one generation to the next is 
not new; the first suggestions have been attributed to Jean-Baptiste Lamarck. He exemplified 
his thoughts with an example of the giraffe. According to Lamarck, giraffes developed long 
necks by reaching towards the treetops to eat and this caused the necks to get progressively 
longer. This trait would then be inherited by the offspring and so forth. His thoughts were later 
rejected and forgotten with the discovery of Mendelian inheritance. The discovery of epigenetic 
mechanisms that might explain how a trait can be inherited without a mutation in the DNA 
code has led to a rebirth of “Lamarckism”. The results from the Överkalix cohort, together with 
the Dutch Winter Hunger study, implies that this phenomenon of inter- and/or transgenerational 
epigenetic inheritance also occurs in humans and has received a lot of attention both by the 
general public and the scientific community (Kaati et al., 2002; Pembrey et al., 2006; Lumey 
et al., 2007). These studies and their implications for transgenerational epigenetic inheritance 
will be described in more detail later in section 1.5.2. 
The term intergenerational or multigenerational epigenetic inheritance is generally used to 
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describe a transmission from one generation to the next. On the other hand, transgenerational 
epigenetic inheritance refers to a transmission of an environmentally triggered phenotype, to a 
generation that was not exposed to the initiating stimuli. If using a maternal lineage, there has 
to be a change in the F3 generation for it to be a true transgenerational effect, since also the 
fetus and its primordial germ cells are exposed together with F0 generation, which will in the 
end become the F2 generation, with the same stimuli. In contrast, if using a paternal lineage, it 
is sufficient for the F2 generation to exhibit a phenotype for it to be a true transgenerational 
effect (Figure 6) (Heard and Martienssen, 2014).  
 
 
Figure 6 - Environmental effects across generations. Environmental exposure of the F0 generation will also directly expose the F1 generation, and in the case of a maternal linage also the F2 generation. A true  transgenerational phenotype needs to be observed in the F2 generation when using a paternal linage or the F3 for a maternal. 
 
Epigenetic inheritance was first described in plants (McClintock, 1961). Others have also 
shown how traits regulated by epigenetic mechanisms can be inherited by plants and one of the 
better illustrations of this is how two complex traits, root length and flowering time is due to 
inheritance of epigenetic quantitative traits loci that can account for 90% of heritability (Cortijo 
et al., 2014). 
One of most well-studied examples of epigenetic inheritance in mammals is the agouti viable 
yellow (Avy) gene (Morgan et al., 1999; Martin et al., 2008). An insertion of a retrotransposon 
IAP 100 kb upstream from the agouti gene leads to a yellow fur, obesity and diabetes in these 
mice. The phenotype can be rescued with supplementation of various methylation donors, i.e. 
vitamin B12, folic acid and betaine, which results in wild-type coat color and a decrease of 
morbidities (Cooney et al., 2002; Waterland et al., 2006). Another interesting observation is 
how this is only inherited through a maternal linage (Daxinger and Whitelaw, 2012).  
A more recent example of non-Mendelian triggered obesity is how a Trim28 haploinsufficiency 
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state can induce bistable obesity and how obesity could be explained by enrichment of 
paternally expressed imprinted genes in Trim28+/D9 mice. Furthermore, humans with low 
TRIM28 adipose expression showed increased obesity prevalence together with an imprinted 
gene dysregulation similar to the Trim28+/D9 mice, suggesting that polyphenism could partly 
explain the obesity pandemic that the world is experiencing (Dalgaard et al., 2016).  
1.5.1 Maternal inter- and transgenerational epigenetic inheritance in 
mammals 
Many studies have investigated the effect of an altered in uterus milieu on the offspring 
(Fowden and Forhead, 2004; King, 2006; Bruce and Hanson, 2010). Depending on the 
intervention and organism used, there are some differences in the observed phenotype of the 
offspring. Some methods used to induce intrauterine growth restriction  are protein restriction, 
calorie restriction or ligation of the uterine artery of pregnant females (Simmons et al., 2001; 
Resnik, 2002; Fernandez-Twinn et al., 2005). When performed in rats, the later method results 
in a progressive dysfunction in insulin sensitivity and insulin secretion in a similar fashion as 
observed in people with type 2 diabetics (Stoffers et al., 2003). To cope with the nutritional 
limitation, the cells of the fetus respond by reprogramming their mitochondrial function, 
causing  the mitochondria to be dysfunctional in adulthood. This has been observed in several 
different tissues such as skeletal muscle, liver and β-cells, regardless if utilizing a protein 
restriction model or uterine artery ligation to induce the intrauterine growth restriction (Park et 
al., 2004; Chang et al., 2013; Sakai et al., 2013). There is evidence of both histone alterations 
at specific targets, such as the key coactivator Ppargc1, as well as global hypomethylation (Fu 
et al., 2004).  
Undernutrition is still a real threat for millions of people around the world (Black et al., 2013). 
However, the number of people suffering from overweight and obesity have surpassed the 
amount of people suffering from malnutrition and is predicted to increase (NCD-RisC, 2016).  
Both animal and human studies have confirmed that exposure of over-nutrition in a prenatal 
state can lead to maladaptive metabolism in the adult offspring. The obesity affects the oocyte 
directly and the phenotypes observed in the offspring are not only due to changes in the 
intrauterine environment (Jungheim et al., 2010; Marquard et al., 2011). This is nicely 
illustrated by transferring a two-cell embryo from obese mice to normal weight mice and 
thereby separating the fetus from the obese uterine milieu, which induces changes in the brain 
reward system and alters gene expression in the placenta (Grissom et al., 2014; Sasson et al., 
2015).  
Two possible mechanisms that can cause impaired metabolism are oxidative stress and 
inflammation. Obesity increases whole body inflammation both in a pregnant and non-pregnant 
state (You et al., 2004; Roberts et al., 2011). Furthermore, placentas of obese women have 
increased mRNA levels of genes associated with oxidative and inflammatory stress and 
therefore changes in gene expression can contribute to an inflammatory or state of the uterus 
(Roberts et al., 2011). Oxidative stress appears to have a direct link with the maladaptive 
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metabolism developed by the offspring of the obese mother. If antioxidant supplements are 
added to a pregnant dam’s diet, it can avert the negative effects in the offspring’s future 
metabolic health (Sen and Simmons, 2010). Although there is a clear difference in the 
abundance of a number circulating metabolites and cytokines in normal weight versus obese 
pregnancies, which may cause negative phenotypes in the offspring, it is still unclear whether 
these two different signaling pathways are contributing.   
An F1 generation can be directly affected by changes in the uterus milieu. However, 
environmental stress can be inherited to, at least, the F3 generation. Toxins have been used as 
environmental stressors’, causing’ different pathologic responses such as obesity, maladaptive 
social behavior and polycystic ovary syndrome in the offspring (Nilsson et al., 2012; 
Wolstenholme et al., 2012; Chamorro-Garcia et al., 2013). Furthermore, a uterine exposure of 
a high-fat diet cause obesity in the F3 female, inherit through the paternal lineage (Dunn and 
Bale, 2011). Together this demonstrates how different environmental stimuli can cause 
phenotypic changes that are later inherit by future generations. 
1.5.2 Paternal inter- and transgenerational epigenetic inheritance in 
mammals 
Although the maternal environment affects future well-being of the offspring, whether the 
fathers environment could add to this is less well appreciated. Traditionally, studies on a 
paternal diet have focused on sperm count and motility since the spermatozoon does not 
contribute much more to the offspring than the DNA code it is carrying. This view has been 
challenged and mounting evidence showing how the fathers’ lifestyle can be connected to 
offspring phenotype. Although some of the studies have used toxin exposure as an intervention 
(Skinner et al., 2010; Lombo et al., 2015; Mao et al., 2015), the following text will focus on 
role of the dietary interventions and possible mechanisms for the transfer.  
The previously mentioned studies from the Överkalix cohort are the most well-known 
examples of how the fathers’ diet could influence his offspring cardiometabolic health in 
humans (Kaati et al., 2002; Pembrey et al., 2006; Bygren et al., 2014). In Överkalix, the crop 
harvest records are available for several centuries, and since the village was practically isolated 
during the winter, researchers were able to estimate the food accessibility around 1900 and then 
correlate this with morbidities in the grandchildren of the starvation survivors. One of their 
most striking findings was that the risk of developing metabolic diseases in the grandchildren 
varied with the grandparental exposure to the food supply during adolescence (Kaati et al., 
2002; Pembrey et al., 2006). Few human studies have focused on male-line inheritance of a 
diet, and the studies from the Överkalix cohort showed how an ample or inadequate paternal 
diet might influence the offspring phenotype.  More importantly, the result from this cohort 
have triggered an increasing interest of transgenerational epigenetics, which have in turn led to 
a number of studies in animals confirming this phenomena (Carone et al., 2010; Ng et al., 2010; 
Fullston et al., 2013; Wei et al., 2014). 
The first study to describe how a paternal high fat diet could influence the metabolic health of 
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the offspring in mammals (in a controlled environment) used F0 male rats fed a high-fat diet 
before mating with females on a control (chow) diet (Ng et al., 2010). This intervention resulted 
in β-cell dysfunction in the F1 female offspring, accompanied with changes in the pancreatic 
transcriptome and methylome. Furthermore, the offspring from high-fat fed males showed 
increased adiposity, increased body weight, and impaired glucose tolerance (Ng et al., 2010). 
A follow-up study in the same animal cohort showed five networks, (mitochondrial and cellular 
response to stress, telomerase signaling, proliferation, cell cycle and cell death and survival) 
were significantly changed in the retroperitoneal adipose tissue transcriptome (Ng et al., 2014). 
A similar study published more evidence of an intergenerational inheritance in response to diet 
(Carone et al., 2010). The founding F0 males were fed a low protein diet that caused an 
increased expression of hepatic genes involved in lipid and cholesterol biosynthesis. However, 
the methylome in the spermatozoa was concluded to be for the most part unaffected by the diet 
(Carone et al., 2010).  
The first evidence of a true paternal transgenerational epigenetic inheritance due to a diet 
intervention in mammals was published in 2013 (Fullston et al., 2013). Earlier mentioned 
studies did not follow the offspring phenotype further than a F1 and are per definition 
intergenerational studies. F0 male mice were fed a high-fat diet and then bred with control 
females. The main phenotype in the mice deriving from the high-fat-fed founder was increased 
adiposity. Four miRNAs were identified to be altered in the high-fat-fed male founders sperm; 
miR-133b, miR-340, 196a and miR-205. The investigated predicted targets were down 
regulated in both the sperm and testis, following the dogma that miRNAs down-regulates the 
expression of its targets. The alterations in the miRNAs expression were suggested to explain 
how the environmental information (high-fat diet) was transferred from one generation to the 
next. (Fullston et al., 2013).  
1.5.3 Inter- and transgenerational epigenetic inheritance in other animal 
models 
Animal models such as Caenorhabditis elegans (C. elegans) and Drosophila melanogaster (D. 
melanogaster) have been used to investigate inter-/transgenerational epigenetic inheritance in 
response to a diet intervention (Rechavi et al., 2014; Öst et al., 2014). These studies are 
interesting since these models lack DNA methylation, but still show an altered phenotype in 
the offspring, indicating that methylation does not have to be the main epigenetic marker 
responsible for transmitting environmental information to future generations.  
A paternal high or low sugar diet in D. melanogaster can increase the susceptibility of 
obesogenic diet in the F1 offspring, demonstrating that there is a U-shaped response to the diet 
intervention (Öst et al., 2014). The two extremes showed altered feeding behavior, with 
increased food intake and maladaptive alteration of the lipid store mobilization. The phenotype 
was not transmitted further to the F2 generation making it an intergenerational event. In C. 
elegans, starvation of the F0 founders’ increases lifespan and a significant enrichment of genes 
associated with nutrient reservoir activity in the F3 generation (Rechavi et al., 2014). Thus, 
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these studies provide evidence that transgenerational epigenetic inheritance is conserved 
between several species.  
1.5.4 Possible mechanisms for paternal non-Mendelian inter- and 
transgenerational inheritance 
The main biological contribution from a male to its offspring is the haploid genome, and this 
has lead researchers to mainly target the sperm in their search for epigenetic carriers that could 
explain non-Mendelian inheritance (Rando, 2012). There are also other possible contributing 
factors such as seminal fluids or unintended transfer of microbiota (Theodorou, 2013; 
Bromfield et al., 2014). Here the focus will be on the three earlier mentioned epigenetic 
markers: DNA methylation, histone modifications and sncRNAs. 
DNA methylation is the most well-studied of these potential epigenetic carriers. Several 
researchers investigating paternal non-Mendelian inheritance have measured changes in 
methylation in both spermatozoa and metabolic active tissues in the offspring (Carone et al., 
2010; Ng et al., 2010; Wei et al., 2014). However, in most cases the differentially methylated 
regions (DMRs) in tissues of the offspring have not been overlapping with DMRs in the 
father/grandfathers spermatozoa (Carone et al., 2010; Fullston et al., 2013). This appears to 
undermine the rather simplistic hypothesis that a diet can cause changes in the sperm 
epigenome that will escape erasure in the early development and is maintained into the somatic 
tissue, and thereby explaining the offspring phenotype. Furthermore, there are doubts that 
Lamarckian inheritance is a real phenomenon in mammals (Bromfield et al., 2014; Iqbal et al., 
2015; Weiss, 2015). A well-executed study investigating transgenerational inheritance induced 
by different chemical compounds (vinclozolin, bisphenol A and bis(2-ethylhexyl) phthalate) 
provided evidence against persistent methylation changes in the non-exposed generation’s 
germ cells (Iqbal et al., 2015). Furthermore, a key caveat against DNA methylation as an 
epigenetic carrier of paternal environmental information is the almost complete erasure of 
methylation that takes place right after fertilization (Oswald et al., 2000; Ly et al., 2015). Even 
though parts of the methylated genome are able to escape erasure, it is unlikely that methylation 
would be the main epigenetic carrier since the imprinted control regions are neither more 
protected, nor more responsive to parental undernutrition. However, the imprinted genes that 
are affected have been proposed to play a role in the fetal response to undernourishment, and 
potential health issues in the offspring adult life (Radford et al., 2012).  
Overall, the evidence that DNA methylation is able to transfer information regarding the 
paternal milieu is at this point correlative. Functional studies to directly address this issue are 
currently challenging, although rapid technical advances should make relevant experiments 
possible in the near future. Until then, the debate will continue as to whether or not DNA 
methylation is a non-Mendelian mechanism capable of transferring environmental information 
between generations. 
Changes in histone modifications have also been associated with dietary intervention causing 
an inter-/transgenerational response in the offspring (Carone et al., 2010; Siklenka et al., 2015; 
 18 
Terashima et al., 2015). Although, a majority of the histone proteins are exchanged into 
protamine’s during spermatogenesis and thereby enabling a tighter packaging of the DNA 
code, some histones are maintained and might possibly transfer environmental information 
between generations. A high-fat diet can alter specific histone retention at genes involved in 
the regulation of development in mice spermatozoa (Siklenka et al., 2015). A paternal high 
sugar diet is able to modulate the chromatin state in D. melanogaster spermatozoa and in their 
offspring (Öst et al., 2014). Together, this suggests that histone modifications is a possible 
epigenetic carrier. 
Another argument for the possible importance of histone modifications in inter-
/transgenerational inheritance context, is that the common models C. elegans and D. 
melanogaster do have histones, but lack DNA methylation (Öst et al., 2014). Histone 
methylation can be inherited in a transgenerational manner. One example of this is how changes 
of histone methylation in F0 sperm can impair survival and development of the offspring. These 
effects can be inherited to at least the F3 generation without changes of the genome or DNA 
methylation (Rechavi et al., 2014). However, the same study also observed changes in sperm 
RNA, suggesting that an interacting complex mechanism between histone modification and 
RNA is responsible for transgenerational epigenetic inheritance.  
sncRNAs are altered in many in inter-/transgenerational epigenetic inheritance studies (Ng et 
al., 2010; Fullston et al., 2013; Rechavi et al., 2014). A majority of studies have been focused 
on miRNAs, but other classes such as piRNAs, siRNAs and tRNA fragments has also been 
observed to be changed. One logistical advantage is that it is relatively easy to perform 
functional studies with sncRNA in comparison to DNA methylation and histone modifications, 
by extracting sncRNAs from F0 male and then injecting them into fertilized oocytes. Mice on 
a “Western diet”, i.e. a diet with both high fat and sugar content, have upregulated levels of 
several miRNAs, and control one-cell embryos injected with mmu-miR-19 present an impaired 
metabolic phenotype (Grandjean et al., 2015). Furthermore, RNA-pools extracted from sperm 
exposed to different treatments have been injected into embryos resulting in similar phenotypes 
as the offspring conceived in a natural manner (Rodgers et al., 2015), demonstrating that 
miRNAs can play a role in transferring information from the paternal environment in an inter-
/transgenerational manner.  
Recently, tRNA fragments have been suggested as mediators of epigenetic inheritance. When 
the sperm travels through the epididymis the abundance of different sncRNAs changes 
significantly and the increase of fragmented tRNAs is the most distinctive. Two individual 
groups have provided evidence of how a paternal diet intervention can alter amounts of the 
fragmented tRNAs and also how microinjections of these can alter gene expression of 
metabolic pathways in early embryos and adult offspring (Chen et al., 2016; Sharma et al., 
2016). A counterargument against sncRNAs as a carrier of paternal epigenetic information is 
that sperm carries a small amount of sncRNA’s in comparison to an oocyte, thus questioning 
if sperm could carry enough sncRNA to actually make a difference. However, an increasing 
number of studies utilizing different animal models and approaches have suggested that even 
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small amounts of sncRNA can have an impact. 
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2 AIMS 
Metabolism is regulated by a complex interplay between environmental and genetic factors. 
The human genome has not undergone any radical changes during the last decades, but our 
way of life has drastically changed. These environmental changes have caused a surge of 
metabolic diseases such as obesity and type 2 diabetes. The overall aim of this thesis is to study 
the effect of environmental interventions on metabolism. The specific sub-aims were to: 
 Determine if there is a different skeletal muscle trasncriptomic response to an acute 
exercise bout between healthy individuals and individuals with type 2 diabetes.  
 
 Determine the effect of paternal and grandpaternal high fat diet on tissue-specific and 
whole body metabolism in subseqent generations. 
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3 EXPERIMENTAL PROCEDURES AND METHODOLOGICAL CONSIDERATIONS  
Selected methods used in the studies of this thesis are presented here. The aim of this section 
is not to provide detailed information regarding the methods used (for this I refer to the method 
sections of the specific manuscript), but rather to discuss advantages or drawbacks of the 
different methods. All studies were approved by the local ethical committee and conducted 
accordingly. 
3.1 HUMAN COHORT 
In study I, a human cohort consisting of 18 normal glucose tolerant men and 18 men diagnosed 
with type 2 diabetes was recruited to perform a 30-minute bout of cycling. Blood and skeletal 
muscle samples were taken before, just after and 3-hours after the bout of exercise. Participants 
undertook an oral glucose tolerance test to evaluate the status of their glucose metabolism 
(Table 4). 
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Table 4 – Anthropometric data of the participants in study I that are included in this thesis.  
 * Significant difference using unpaired Students t-test.  Data are represented as mean ± SEM. N = 18 
3.1.1 Exercise protocol 
The participants performed a maximal VO2 uptake test as part of the screening process. 
Maximal heartrate and maximal workload were also recorded. The measured maximal heartrate 
was later used to individualize the resistance during the exercise bout, with a target workload 
corresponding to 85% of maximum heartrate. A 5 min warm-up with increasing resistance 
preluded the bout.  
3.1.2 Skeletal muscle biopsies  
There are different methods of obtaining a skeletal muscle biopsy; one can use the “Bergström 
needle”, “open muscle biopsy” or the “Weil-Blakeley conchotome”, to mention some. All 
possible methods have different advantages or disadvantages. In study I, we used the Weil-
NGT T2DAge 60.3 ± 1.4 61.0 ± 1
BMI (kg/m2) 27.5 ± 0.7 28.6 ±0.6Body Fat (%) 28.7 ± 1.3 30.1 ± 1.0Blood Pressure Diastolic (mmHg) 78.7 ± 1.7 78.8 ± 2.1Blood Pressure Systolic (mmHg) 130.1 ± 3.0 135.6 ± 3.2Fat Mass (kg) 25.4 ± 1.5 27.0 ± 1.7HbA1c(mmol/L) 35.6 ± 0.9 47.8 ± 2.1Hip (cm) 109.9 ± 1.5 102.3 ± 2.3HOMA-IR* 1.5 ± 0.2 3.6 ± 0.5Lean mass (kg) 60.0 ± 1.3 60.1 ± 2.0Length (m) 1.8 ± 0.0 1.8 ± 0.0Max heartrate (beats/min) 164.5 ± 2.2 164.1 ± 3.8Max workload (Watt) 246.6 ± 10.9 201.1 ± 11.1ALAT (µkat/L)* 0.4 ± 0.0 0.6 ± 0.1ASAT (µkat/L) 0.4 ± 0.0 0.5 ± 0.0Cholesterol (mmol/L)* 5.3 ± 0.2 3.9 ± 0.2Creatinine (µmol/L) 83.2 ± 3.2 80.1 ± 2.7Glucose OGTT 0 min (mmol/L)* 5.2 ± 0.1 7.4 ± 0.4Glucose OGTT 120 min (mmol/L)* 5.6 ± 0.4 14.4 ± 0.7HDL (mmol/L)* 1.4 ± 0.1 1.2 ± 0.1LDL (mmol/L)* 3.4 ± 0.2 2.1 ± 0.2Triglycerides (mmol/L) 1.0 ± 0.1 1.2 ± 0.2Resting Pulse (beats/min)* 58.8 ± 0.1 68.7 ± 2.2C-peptide (nmol/L) 0.6 ± 0.1 1.0 ± 0.1Waist/Hip ratio* 1.0 ± 0.0 1.0 ± 0.0Waist (cm) 98.8 ± 2.1 104.1 ± 1.9Weight (kg) 88.3 ± 2.3 89.5 ± 3.3
Relative VO2 max (ml/kg/min) 36.4 ± 2.0 31.4 ± 2.0
Absolute VO2 max (ml/min) 3162.8 ± 141.1 2753.4 ± 163.9
  25 
Blakeley conchotome. The subjects’ skin is washed and local anesthesia is applied before a 
small, 2-3 cm, incision is made above the vastus lateralis. The surgeon then goes through the 
subcutaneous fat depot to open the muscle fascia. Muscle biopsies weighing ~ 20-70 mg are 
acquired by pinching the head of the conchotome to the muscle and firmly pulling it out. The 
procedure is relatively easy to perform, several biopsies can be obtained from the same incision 
and it is not overly invasive, which reduces both the risk of infection and recovery period. 
However, the biopsy size is smaller compared to other methods, such-as “open muscle biopsy”, 
and the biopsy is also less intact. Thus, when gathering muscle biopsies to perform RNA or 
DNA experiments, the Weil-Blakeley conchotome method is an excellent option. 
3.2 ANIMAL EXPERIMENTS 
In biological research, it is often necessary to utilize different models due to logistical, financial 
and/or ethical reasons. Furthermore, it makes it possible to exclude confounding factors to a 
greater degree than it is possible to do when studying humans. Doing so, we can expand and 
deepen our knowledge regarding physiological processes considerably faster. In study II, III 
and IV, we used Sprague Dawley rats as a model to study transgenerational inheritance. 
Rodents are excellent models when studying physiology. They are mammals, their genomes 
are sequenced, and the fact that they have been used as models for several decades means that 
we know a lot about how to translate rodent physiology to human physiology. We chose rats 
as a model rather than mice. Although, it is more expensive to house rats – due to their size 
they require more cages and more food – there were other advantages. Since our study design 
was based on an intergenerational study by (Ng et al., 2010), it meant that we could directly 
compare our results with theirs. Furthermore, since rats are larger, we obtained more material 
(tissue) to work with and could thereby reduce the number of animals needed.  
3.2.1 Breeding design 
In order to investigate the transgenerational effect of a high fat diet we used a paternal line of 
Sprague Dawley. The founder generation was either fed a high-fat diet (mix of two different 
high-fat diet pellets consisting of either 42 E % or 45 E % from fat) or a chow diet. As 
previously mentioned, our study design was based on a study from Margret Morris’ group (Ng 
et al., 2010), hence the choice of the high-fat diet diet and span of treatment. After 12 weeks, 
male rats bred with chow-fed female rats to generate the F1 generation. To generate the F2 
generation, chow-fed F1 male rats (from a high-fat-fed or chow-fed father) mated with 
independent female rats. Both the F1 and F2 generations were divided into different subgroups 
and fed either a high-fat diet or a chow diet. Resulting in four different study groups per 
generation (Figure 7). 
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 Figure 7 – Schematic illustration of the study design: To engender the F1 offspring, F0 male Sprague-Dawley rats fed a high-fat diet (F0-HF) or a control chow diet (F0-CD) during 12 weeks, before they were mated with control fed females (CTL,CD). F1 male rat, fed a control-diet, mated with females from an independent line to generate the F2 generation. Both generations were studied at 10 weeks of age, a sub-group of rats were subjected to chow or high-fat diet for 12 weeks. Adapted from (de Castro Barbosa et al., 2016) (study II). 
 
3.2.2 Animal phenotyping 
Our major tools to assess the offspring’s metabolic phenotype were glucose and insulin 
tolerance tests. Food was removed prior to the tests to ensure that the animals were fasted before 
injection with a glucose or insulin solution into the peritoneum, and blood from the tail vein 
was extracted to measure the blood glucose level. Furthermore, we monitored the weight gain 
of individual animals on a weekly basis, as well as food intake. Another interesting 
measurement would have been energy expenditure. Unfortunately, we did not have access to 
metabolic cages that could house rats at this time. At endpoint, we collected and measured the 
weight of different fat pads, muscles and other relevant tissues, making it possible to estimate 
body composition. The ideal way of measuring this would had been magnetic resonance 
imaging (MRI). However, due to logistical reasons, this was not possible. 
3.3 METHODS TO MEASURE GENE EXPRESSION 
All cells in a single organism share the same genetic code. However, the gene expression of 
different cell populations (i.e. transcribed RNA molecules) are vastly diverse. The univariate 
method of reverse transcription-quantitative polymerase chain reaction (RT-qPCR) is one of 
the most commonly used methods to measure gene expression. It has the advantage of being 
relatively inexpensive, easy to perform, specific, and highly sensitive. Furthermore, it is 
relatively easy to perform traditional statistical methods, such as Student’s t-test and different 
versions of ANOVAs, with the results from a RT-qPCR. However, it does suffer from the same 
problem as all univariate methods: the target needs to be previously known, and the method is 
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more suited for hypothesis testing studies, as opposed to hypothesis generating studies.  
It is getting more and more common to perform so-called ‘omics studies were the whole 
genome expression is measured in a sample at once. One way of doing this is by gene array. A 
gene array contains thousands of DNA probes, which align with specific parts of the genome. 
When a sample DNA strand hybridizes with the probe, it gives a fluorescent signal that is then 
measured and quantified. Gene arrays have the advantage of being (for an ‘omic approach) 
inexpensive and nowadays analysis of the data is well established. However, just as with other 
‘omics methods, the massive amount of data is a double-edged sword. Traditional statistical 
tests, such as Student’s t-test and ANOVA, are not designed for this type of data. There have 
been different approaches to deal with the analysis of this type of data and one of the most 
common approaches is to apply a multiple comparison test. In addition to this, results from 
probes that are giving a low signal need to be validated, most commonly by qPCR, to ensure 
that the signal is not due to ‘noise’.  
Another method of measuring whole genome expression is by RNA sequencing (RNA-seq). 
There are different ways of preparing a RNA-seq library, depending on the focus of the study 
in question. In short, one way is to first perform an rRNA depletion and then fragment the 
remaining RNA before converting into cDNA. The cDNA is then amplified using PCR and, 
finally, sequenced. Although the cost of RNA-seq is still relatively high, it is diminishing. 
Compared to gene arrays, it has higher sensitivity, is more precise, and is much more suited 
when investigating non-coding RNA. In addition to this, RNA-seq does not require a priori 
knowledge of the samples genome; something that is required for a gene array. In this thesis, 
all three mentioned methods of measuring gene expression were used. RT-qPCR and gene 
arrays were used in studies II, III and IV; and RNA-seq in studies I and II. 
3.4 BIOINFORMATICS 
Bioinformatics is an interdisciplinary field using mathematical and programing approaches to 
investigate the massive amounts of data acquired from various ‘omics methods into meaningful 
biologic insights. If a data matrix consists of 20 000 genes and 100 samples, it means that there 
will be 2 000 000 data cells. It is not possible to analyze this amount of data manually and there 
is a big risk of “not seeing the forest for the trees” if not using the correct set of tools. One 
example of how to make sense of this data is to apply different clustering algorithms. 
Nowadays, there are many well-established pipelines and methods to analyze individual 
‘omics, but how to integrate the different ‘omics types is still challenging. With the increased 
usage of ‘omics-based methods, the need to understand the rapidly expanding field of 
bioinformatics has increased in equal measure.  
Study I is primarily utilizing the statistical program “R” and freeware packages that are 
available from BioConductor, for the bioinformatics analysis. The RNA-seq alignments were 
performed by National Genomics Infrastructure, at Science for Life Laboratory, Stockholm. 
We used a negative binomial distribution method, DESeq2, to determine the differential gene 
expression of acute exercise in the two groups (Love et al., 2014). After this, we used different 
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methods of clustering: principal component analysis (PCA), gene ontology over-
representation, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis 
(Tarca et al., 2009; Yu et al., 2012). The gene arrays of studies II-IV were performed and 
normalized using the console plier method, at Bioinformatics and Expression Analysis (BEA) 
core facility, Karolinska Institutet, Huddinge. In studies I-IV, we used gene set enrichment 
analysis (GSEA), from Broad Institute, to assess transcriptomic alterations (Mootha et al., 
2003; Subramanian et al., 2005).  
3.5  FIGURES INCLUDED IN THE THESIS 
The figures included in the introduction were made in PowerPoint using freely available 
medical images from two online sources: https://smart.servier.com/ and 
http://www.somersault1824.com/.  Figures in the method and result/discussion sections are 
adaptations from studies I-IV.
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4 RESULTS AND DISCUSSION 
4.1 RESPONSE TO ACUTE EXERCISE IN TYPE 2 DIABETES  
The benefits of exercise are well known (Gabriel and Zierath, 2017). However, it is not fully 
understood through which pathways these beneficial adaptations occur or if they are differently 
regulated in people diagnosed with type 2 diabetes. Previous studies investigating the effects 
of exercise in patients with type 2 diabetes have mainly focused on the effects of training, rather 
than acute effects of exercise (Boule et al., 2001). It is clear that long-term effects, such as 
decreased HbA1c and increased aerobic capacity, are positive for both healthy and diabetic 
individuals.  However, less is known about the acute effects of exercise in individuals with a 
type 2 diabetes diagnosis.  
To determine the exercise-induced pathways in skeletal muscle we used an unbiased approach 
by sequencing RNA from skeletal muscle biopsies of healthy or type 2 diabetesmiddle-aged 
men in study I. Data were then analyzed in the statistical program “R”, (Figure 8). The initial 
transcriptomic response of both the healthy control group and the type 2 diabetes group were 
similar. Some of the top gene ontologies were expected gene pathways related to blood vessel 
development and regulation of MAPK cascade (Gomez-Cabrera et al., 2005; Hoier et al., 2012) 
(Figure 9A-B). Several of the genes upregulated just after the exercise were associated with 
gene transcription, such as early growth response (EGR), protein 1, EGR2 and MYC. Increased 
expression of transcription inducing genes immediately after exercise is expected (Yu et al., 
2001; Safdar et al., 2011). Our results suggest that in this early post-exercise phase, the skeletal 
muscle of both groups is primed for further transcription and remodeling. Supporting this 
notion, another study with a similar design found that most genes upregulated directly after 
exercise are either transcription factors or genes related to RNA transport (Hansen et al., 2015). 
This study combined a metabolic and transcriptomic analysis. This integrative ‘omics approach 
has shown the insulin signaling pathway to be highly affected by acute exercise. In contrast, 
we did not observe any transcriptomic changes in the insulin singling pathway. However, it is 
likely that these alterations would have been uncovered by an integrated approach with 
phosphoproteomics or metabolomics.  
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 Figure 8 – Schematic illustration of the study design. Normal glucose tolerant (NGT) and type 2 diabetic (T2D) subjects were recruited and performed an acute bout of aerobic exercise at 85% of maximal heartrate. RNA sequencing was performed on skeletal muscle biopsies taken at three time-points: Before exercise, “rest”; immediately after exercise, “exercise”; and after three hours of resting after the exercise bout; “recovery”. RNA sequencing data were analyzed using different bioinformatics tools, mainly in the statistical program “R”. 
 
Strikingly, the type 2 diabetes group had a much higher number of differentially expressed 
genes compared to the control group at recovery (Figure 10A). The majority of genes altered 
in the control group are also altered in the type 2 diabetes group, indicating that the exercise 
response is still somewhat shared between the two diagnosis groups. This pattern of acutely 
increased transcription after exercise is in line with previous observations  in both healthy and 
diabetic populations (Hansen et al., 2015; Rowlands et al., 2016). Thus, it is not suprising to 
see an increase in the amount of altered transcripts in the recovery time-point. Indeed, one of 
the most highly upregulated ontologies in the exercise time-point was related to gene 
transcription. After the initial high energy demand from the actual work has reduced, the 
muscle cell can redistribue more energy to both transcription and translation. 
When performing a gene ontology over-representation test on the upregulated genes identified 
at the recovery time-point, we  identified the “inflammatory response as the most significant 
ontology in both groups  (Figure 10B). Even if inflammation is often associated with 
deleterious conditions such as the metabolic syndrome and obesity, it is a key component 
required for myogenesis and remodeling of skeletal muscle following exercise (Neubauer et 
al., 2014). The necessity of inflammation for an adaptive exercise response is demonstrated by 
how the use of non-steroidal anti-inflammatory drugs can blunt positive adaptations to exercise 
(Trappe et al., 2002). Therefore, an inflammatory exercise response is expected. However, 
Hansen et al., did not observe a similar inflammatory response (Hansen et al., 2015), which 
may be due to a lower exercise intensity as compared to our study. 
The number of genes we observed to be altered in the type 2 diabetes subjects could be a result 
of infiltration by non-muscle cells and the gene ontology over-representation test indicated 
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leukocytes as a possible source of transcripts. Whether the heightened inflammatory response 
in the diabetic individuals is deleterious remains to be determined. However, as prolonged 
training is benifical for diabetic patiens, the inflammatory response is either benign or lessens 
over time as the subjects get acclimated to the exercise during the training period. 
 
 
Figure 9 – A) Overlap of differentially expressed genes at the exercise time point between T2D and NGT subjects. Differentially expressed gene inclution criteria, false discory rate ≤ 0.05 and ± 0.5 log2 fold change. B) Gene ontolgy over-representation plot of upregulated genes in the exercise timepoint.  
 
 
 
Figure 10 – A) Overlap of differentially expressed genes at the “recovery” time point between T2D and NGT subjects. Differentially expressed gene inclution criteria, false discory rate ≤ 0.05 and ± 0.5 log2 fold change. B) Gene ontolgy over-representation plot of upregulated genes in the “recovery” timepoint.  
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Cytokines and chemokines are crucial mediators of inflammation and leukocyte migration. 
Although the transcriptomic results indicated a strong inflammatory effect, it is important to 
validate these type of results on a protein level.  It is, in the end, the proteins that will act as 
attractants and an increase in transcription does not always lead to a similar increase of 
translation. Thus, we sought to evaluate whether exercise or disease state altered the abundance 
of CCL2, CCL21, CX3CL, CXCL1, CXCL9, CXCL10, CXCL12, CXCL16 and IL-16 protein 
levels (Figure 11). Most of the cytokine and chemokine levels were altered by exercise. Even 
more interesting was the finding that there was an overall difference between the control and 
type 2 diabetes groups in CCL2, CCL21, CXCL1, CXCL10 and CXCL16 proteins. The post 
hoc tests revealed that the abundance of CCL2, CCL21, CXCL10 and CXCL16 was different 
between the diagnosis groups in the recovery time-point. Several of these chemokines have 
previously been shown to be upregulated at both protein and mRNA levels by exercise (Della 
Gatta et al., 2014; Gjevestad et al., 2017). However, to our knowledge this is the first study to 
show a difference between normal glucose tolerant controls and type 2 diabetic subjects. In 
summary, both the protein abundance and RNA sequencing results show comparable effects, 
favoring enhanced leukocyte migration into the skeletal muscle of the diabetic subjects. 
 
 
Figure 11 - Chemokine measured in skeletal muscle after an acute bout of exercise. Data are represented as mean ± SEM. § = interaction effect ‡ = overall effect of group, # = overall effect of exercise, Sidak’s multiple comparison test * = NGT vs T2D; a = Rest vs Exercise; b = Rest vs Recovery; c = Rest vs Recovery.  
In conclusion, we found that men with type 2 diabetes experienced an increased inflammatory 
response to an acute bout of exercise compared to age- and BMI-match normal glucose tolerant 
men. It is possible the inflammatory response will be reduced after a training period, as is the 
case for adipose tissue (Fabre et al., 2018). Additionally, it is possible that ingestion of either 
a low dose of inflammatory nonsteroidal anti-inflammatory drugs or supplementation of 
protein-leucine supplements after the exercise bout could normalize the inflammatory response 
in the diabetic subjects. Consumption of high protein-leucine supplements after exercise can 
increase anti-inflammatory networks in the recovery phase in healthy trained men (Rowlands 
et al., 2016). Even though high doses of nonsteroidal anti-inflammatory drugs lead to decreased 
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protein synthesis post-exercise, moderate doses do not inhibit muscle hypertrophy or increased 
strength (Trappe et al., 2002; Krentz et al., 2008). However, since nonsteroidal anti-
inflammatory drugs can inhibit myoblast differentiation into myotubes, long-term use is 
probably not recommended (Mendias et al., 2004). Finally, our finding highlight the 
complexity of the pathology of type 2 diabetes and raises questions regarding the role of 
inflammation as detrimental or a necessity in exercise and diabetic skeletal muscle. 
4.2 THE IMPACT OF A PATERNAL/GRANDPATERNAL HIGH-FAT DIET ON 
OFFSPRING’S WHOLE BODY METABOLIC PHENOTYPE 
As described in the method section, we fed male Sprague Dawley rats a high-fat diet for 10 
weeks before mating them with chow-fed female rats to generate the F1 generation. To mimic 
the current world scenario, where many children adopt their parents’ dietary habits (Isma et al., 
2012), we further challenged a subgroup of the offspring to a high-fat diet in addition to the 
ancestral dietary intervention. Doing so we found, surprisingly, that female offspring from 
high-fat-fed fathers (Paternal high-fat diet on a high-fat diet (PatHF-HF)) did not increase body 
weight as much as the females from a father on a chow diet (Paternal chow-diet on a high-fat 
diet (PatCD-HF)) (Figure 12A). The PatHF-HF weight resembled the weight of the chow-fed 
rats, even though they were eating the same amount of kcal as the PatCD-HF. Additionally, 
glucose tolerance were worse in PatHF-HF female rats as compared with PatCD-HF rats, 
despite their lower body weight (Figure 12B).  Male F1 rats on a chow diet were used to 
generate the F2 generation, which was also subdivided and challenged with a high-fat diet. The 
whole body metabolic phenotype of the F2 animals were comparable with the F1 generation 
(Figure 12C-D), supporting the assertion that a high-fat diet can cause transgenerational 
alteration of metabolism.  
The phenotype we observed was surprising in several ways. A lower body weight is usually 
associated with a healthier phenotype, decreased mortality risk and higher insulin sensitivity 
(Chan et al., 1994; Adams et al., 2006). In contrast, the PatHF-HF and GpatHF-HF had 
decreased adiposity coupled with increased insulin resistance compared to their PatCD and 
GpatCD littermates. Together, this suggests glucose handling to be dysregulation in the adipose 
tissue, or a redistribution of fat to less metabolically favorable sites. Although, we cannot be 
certain that the decreased whole-body glucose tolerance can be solely attributed to any of the 
metabolically active tissues (adipose tissue, skeletal muscle or liver) investigated in this thesis. 
To elucidate this, we would have had to perform a hyperinsulinemic-euglycemic clamp 
followed by immediate harvesting of the tissues of interest (Hughey et al., 2011) which would 
have enabled us to evaluate the insulin sensitivity and glucose uptake tissue-specifically. 
Unfortunately, due to logistic reasons this was not possible in this study. Another useful 
experiment would have been to place the animals in a metabolic cage to monitor their physical 
activity and energy expenditure (Whittaker et al., 2016). We know that the high-fat fed female 
offspring ate the same amount of calories without gaining as much weight. In light of equivalent 
energy intake, the differences would likely be due to changes in energy expenditure. Utilization 
of the metabolic cages could have shed light on whether this is due to increased activity or 
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increased metabolic turnover. At the time, we did not have access to metabolic cages large 
enough to house rats. Thus, in order to further understand the resultant phenotype, studies 
including these methods are warranted. 
Interestingly, the phenotype was only noted in the female offspring and not the male. This sex-
specific phenotype corresponds with other studies of both inter- and transgenerational 
inheritance (Pembrey et al., 2006; Dunn and Bale, 2011; Dunn et al., 2011; Fullston et al., 
2013). Although many studies report sexual dimorphisms, there are several differences. An 
intergenerational study in rats also reported that the daughters, and not sons, of high-fat fed 
fathers had impaired glucose tolerance (Ng et al., 2010). However, they observed this in chow 
fed female offspring, whereas we only observed this difference in the high-fat fed and not chow 
fed offspring. Another transgenerational study in mice, using a high-fat diet as the intervention 
reported that female offspring, but not male, had increased adiposity (Fullston et al., 2013), in 
contrast to our findings of decreased adiposity in the female offspring.  Studies using maternal 
linages to investigate epigenetic inheritance have also found sex differences in the transmission 
of the phenotypes (Jimenez-Chillaron et al., 2009; Dunn and Bale, 2011). The Överkalix 
studies show that epigenetic inheritance in humans may be sex-specific (Pembrey et al., 2006). 
Together, this is a strong argument that epigenetic inheritance is sex-specific in its character. 
Since the inherited phenotypes do not coincide with each other, it is likely that either the 
different animal models or the different interventions are the cause of these differences. If the 
differences are due to the models, it means that it is not fully conserved between species and 
this raises the question: how come? On the other hand, the notion that different interventions 
(for example high-fat diet vs. a low protein diet) would cause different phenotypes is perhaps 
not that strange. In the end, it is likely that a combination of differences in both species and 
intervention type trigger different responses. 
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Figure 12 - A) Glucose levels during an intraperitoneal glucose tolerance test (ipGTT) (n=9-11 animals; 1 sibling per litters) and B) Body weight curve (n=14-22 animals from 14-17 litters; used more than 1 sibling per litter) of F1 females. D) Metabolic profiling of F2 female offspring after 12 weeks of high fat feeding. D) Blood glucose levels during an ipGTT (n=5-6 litters; 1 sibling per litter) and (D) Body weight curve (n=10-13 animals from 5-6 litters; used more than one sibling per litter). Results are represented as mean ± SEM. Two-way ANOVA followed by Bonferroni post-hoc test: *p≤0.05: PatCD-HF vs PatCD-CD or GpatCD-HF vs GpatCD-CD; ¤p≤0.05: PatHF-CD vs PatCD-CD or GpatHF-CD vs GpatCD-CD; #p≤0.05: PatHF-HF vs PatHF-CD or GpatHF-HF vs GpatHF-CD; +p≤0.05: PatHF-HF vs PatCD-HF or GpatHF-HF vs GpatCD-HF. PatCD-CD: Paternal-Chow on Chow; PatHF-CD: Paternal-HFD on Chow; PatCD-HF: Paternal-Chow on HFD; PatHF-HF: Paternal-HFD on HFD; GpatCD-CD: Grandpaternal-Chow on Chow; GpatHF-CD: Grandpaternal-HFD on Chow; GpatCD-HF: Grandpaternal-Chow on HFD; GpatHF-HF: Grandpaternal-HFD on HFD. Adapted from (de Castro Barbosa et al., 2016). 
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4.3 POSSIBLE EPIGENETIC CARRIERS OF A PATERNAL/GRANDPATERNAL 
HIGH FAT DIET 
 As previously stated, minor environmental 
stimuli such, as a high caloric intake, does not 
alter the genetic code. Thereby, there must be 
another inheritable factor in place that can explain 
inter and –transgenerational inheritance 
metabolic features based on food consumption. 
Epigenetic changes have been suggested as 
putative mechanisms. Paternal models of 
transgenerational inheritance have the advantage 
of limiting possible epigenetic sites to the 
spermatozoa. Therefore, we extracted DNA and 
sncRNA from the spermatozoa of both F0 and F1 
breeders. The methylome was investigated by 
sequencing of MBD-captured DNA fragments. 
Using DiffBind we identified 18 differential 
methylated regions that were altered due to the 
paternal high-fat diet, i.e. PatHF-CD vs. PatHF-
CD, and overlapped the high-fat diet in the F0 
breeder (Figure 13). However, when 
investigating a number of different somatic 
tissues of the F2 offspring, only a few of the 
differential methylated regions were found changed 
in a similar manner. Furthermore, none of the 
regions corresponded with altered levels of mRNA. 
Our data suggests that methylation plays a minor 
role in mediating the transgenerational effect of 
paternal high-fat diet. In contrast, the spermatozoa 
methylome is reported to be different between obese and lean men (Donkin et al., 2016). Pre-
diabetic male mice have also been reported to have an altered sperm methylome (Wei et al., 
2014). Furthermore, the altered sperm methylome in mice was connected to a dysregulated 
metabolism in their offspring. However, other studies have concluded that methylation is an 
unlikely carrier of epigenetic inheritance (Carone et al., 2010; Iqbal et al., 2015). The facts that 
the zygote undergoes several steps of demethylation and remethylation, makes methylation a 
less likely candidate for transferring environmental information between generations. 
Another epigenetic mechanism that has been suggested as an epigenetic carrier is the non-
coding RNAs, especially sncRNAs such as miRNA. The software packed edgeR was used to 
make a differential expression analysis of the sncRNA extracted from F0 and F1 spermatozoa. 
This revealed that piRNAs were the biotype with the highest amount of differential expressed 
genes, ranging between 307 - 1091 affected genes in the different comparisons (Figure 14). 
Figure 13 - Differentially methylated regions common in sperm of F0 and F1 indicates a direct gametic transgenerational reprogramming. Data are represented as log2 of the fold change in F0 (HF vs CD) or F1 (PatHF-CD vs PatCD-CD) founders. Adapted from (de Castro Barbosa et al., 2016). 
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Although, pi-RNAs have been implicated in transgenerational epigenetic studies (Ashe et al., 
2012; de Vanssay et al., 2012), we chose to further investigate the miRNAs, since their 
functions and actions in metabolism are better understood. In addition, the piRNAs exhibit 
lower counts than the miRNAs which indicates that they are less likely to influence the 
development of the zygote.  
 
 
Figure 14 - Amount of differentially expressed sncRNAs i.e. miRNAs, tRFs and piRNAs. In sperm of F0-HF vs F0-CD (n=8-10), F1 offspring of F0-HF (PatHF-CD) vs F1 of F0-CD (PatCD-CD) fed a chow diet or a high fat diet (PatHF-HF vs PatCD-HF) (n=7 per group; 1 sibling per litter). Adapted from (de Castro Barbosa et al., 2016). 
 
We found three miRNAs to be changed in the same direction in the F0-HF vs F0-CD and the 
PatHF-CD vs PatCD-CD rats. Two of these miRNA’s, miR-293-5p and miR-880-3p, were 
downregulated in both comparisons. Whereas let-
7c-5p was found to be upregulated (Figure 15). The 
let-7 family is associated with predisposition to type 
2 diabetes and has a role in the regulation of insulin 
sensitivity and glucose homeostasis (Frost and 
Olson, 2011; Zhu et al., 2011). Therefore, we were 
interested in evaluating Let-7cs functional role in 
somatic tissue from the female offspring, presented 
in section 4.4.1.  
There are other potential epigenetic carriers such as 
microbiota (Elgart and Soen, 2018). However, in our 
study the offspring sharing the same diet with a 
different paternal background (i.e. GpatCD-HF and 
GpatHF-HF) were housed in the same cage. Rodents 
are known coprophages and all offspring would 
thereby ingest the same ancestral microbiome. Therefore, we can reasonably rule out the 
Figure 15 - Let-7c expression in spermatozoa. Values are represented as mean ± SEM. F0-CD: F0 on chow diet; F0-HF: F0 on HFD; PatCD-CD: Paternal-Chow on Chow; PatHF-CD: Paternal-HFD on Chow; PatCD-HF: Paternal-Chow on HFD; PatHF-HF: Paternal-HFD on HFD Adapted from (de Castro Barbosa et al., 2016). 
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microbiome as an epigenetic carrier in our study. More recent studies have also highlighted the 
potential role of tRNA fragments as an epigenetic carrier (Chen et al., 2016; Sharma et al., 
2016). Sharma et al., also found several members of the Let7 family to be altered by their 
dietary intervention. In line with previous findings, our study strongly suggests that the main 
epigenetic carrier in a paternal linage could be the sncRNAs. However, at this point it is not 
possible to single out only one molecule, or even a specific class of the sncRNAs. It is likely 
that several different tRNA fragments and miRNAs are all contributing to the offspring 
phenotype.  
4.4 TISSUE-SPECIFIC ALTERATIONS AS A RESULT OF 
PATERNAL/GRANDPATERNAL HIGH-FAT DIET 
At the end of study II, we collected liver, adipose and skeletal muscle tissue to evaluate the 
tissue-specific alterations introduced by the paternal/grandpaternal high-fat diet. Our main 
approach for exploring these tissues were to perform gene arrays and thereby utilizing an 
unbiased approach when investigating the transcriptomic alterations.  
4.4.1 Adipose tissue 
As previously stated, Let-7c had been observed to be upregulated in the spermatozoa in both 
the high-fat fed F0 male founders and F1 male that had derived from a high-fat fed father. We 
investigated the expression levels of Let-7c in several tissue, including the gonadal white 
adipose tissue, of the F1 and F2 female rats. We found Let-7c to be upregulated in the offspring 
derived from a father/grandfather fed high-fat diet, independent of their own diet (Figure 16). 
The let-7 family of miRNA are involved in glucose metabolism and the insulin signaling 
pathway (Zhu et al., 2011). In vivo overexpression of let-7 causes decreased adiposity and 
impairs glucose tolerance (Frost and Olson, 2011). This is in line with our findings in white 
adipose tissue and the whole body phenotype. The whole body phenotype is only occurring in 
the PatHF/GpatHF animals when they are fed a high-fat diet. However, Let-7c is upregulated 
due to the paternal/grandpaternal high-fat diet in the white adipose tissue regardless of the 
offspring’s diet. Suggesting that upregulation of Let-7c is not enough to cause the impaired 
glucose tolerance. This makes sense from an evolutionary perspective. If the impact of 
ancestral environment on the offspring would surpass the impact of the current environment, 
the offspring would not be able to adapt. Transgenerational epigenetic inheritance should be 
looked upon as a fine-tuning system and it is therefore only natural that it does not come to 
light until the offspring were further metabolically stressed by their own high-fat diet. 
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Figure 16 - Let-7c expression in gonadal white adipose tissue (WAT) in F1 and F2-female offspring. Two-way ANOVA followed by Bonferroni post-hoc test: *p≤0.05: PatCD-HF vs PatCD-CD or GpatCD-HF vs GpatCD-CD; ¤ p≤0.05: PatHF-CD vs PatCD-CD or GpatHF-CD vs GpatCD-CD; #p≤0.05: PatHF-HF vs PatHF-CD or GpatHF-HF vs GpatHF-CD; +p≤0.05: PatHF-HF vs PatCD-HF or GpatHF-HF vs GpatCD-HF. Results are represented as mean ± SEM. PatCD-CD: Paternal-Chow on Chow; PatHF-CD: Paternal-HFD on Chow; PatCD-HF: Paternal-Chow on HFD; PatHF-HF: Paternal-HFD on HFD; GpatCD-CD: Grandpaternal-Chow on Chow; GpatHF-CD: Grandpaternal-HFD on Chow; GpatCD-HF: Grandpaternal-Chow on HFD; GpatHF-HF: Grandpaternal-HFD on HFD. Adapted from (de Castro Barbosa et al., 2016). 
 
To investigate whether the increase of Let-7c had an effect on it target genes we performed a 
gene array on the adipose samples and correlated the predicted targets gene expression versus 
the Let-7c expression. The analysis revealed how the predicted targets of Let-7c were 
downregulated, following the dogma that miRNAs function in a gene-suppressing manner 
(Valinezhad Orang et al., 2014). Our data is consistent with increased Let-7c expression acting 
as a suppressor. The transcriptomic data, together with the whole body phenotype, suggests 
that the adipose tissue is the metabolically active tissue most affected by an ancestral high-fat 
diet. Of note, an ancestral high-fat diet mainly affects the adipose tissue in mice (Fullston et 
al., 2013). 
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4.4.2 Skeletal muscle 
In study III, we used Extensor Digitorum Longus (EDL) muscle from the female F1 and F2 
offspring. The initial GSEA on the transcriptome revealed that there was no effect of the 
grandpaternal diet between the F2 females’ 
offspring, when fed a chow diet. However, 
when comparing the GpatHF-HF vs. 
GpatCD-HF females, we saw that the 
unfolded protein response was enriched in 
skeletal muscle of GpatHF-HF females 
(Figure 17). The result from the GSEA was 
also confirmed using RT-qPCR. The 
unfolded protein response consists of three 
different branches (Walter and Ron, 2011). 
We examined which of these signaling 
pathways could have caused the 
transcriptomic enrichment with Western 
blots. This analysis revealed an increased 
abundance of the chaperone GRP94 and 
cleaved ATF6-α in the GpatHF-HF animals. 
This suggests that the ATF6-α branch is the 
driving arm activation of the unfolded 
protein response. However, when we evaluated the unfolded protein response genes that were 
confirmed to be affected by the grandpaternal diet by RT-qPCR, in the EDL from the F1 
females, there were no difference in expression of these genes. It is possible that the targeted 
approached missed the potential differences and that a full transcriptomic approach would find 
detect this. Another possibility is that the response to the ancestral diet is different depending 
on whether it is an intergenerational or a transgenerational response.  
In contrast to the adipose tissue (study II) and liver (study IV), the grandpaternal high-fat diet 
did not induce any differences on the skeletal muscle transcriptome while the grandoffspring 
were fed a chow diet. Thus, skeletal muscle is less sensitive to changes by diet induced 
transgenerational alterations. Nonetheless, the grandpaternal high-fat diet did affect the 
grandoffspring’s response to their high-fat diet. 
4.4.3 Liver 
In study IV, we explored the effects of a grandpaternal high-fat diet in the liver. Using the 
same approach as in study III, we found several upregulated gene sets in the GSEA. However, 
in the liver we also found gene sets being differently enriched in the offspring on a chow diet. 
Among these, “interferon alpha response”, “interferon gamma response” and “TNF-α signaling 
via NFκB” were enriched in liver of the offspring from chow-fed grandfathers, i.e. 
downregulated in the females from high-fat-fed grandfather, independent on their own diet 
(Figure 18). On a transcriptomic level, the grandpaternal high-fat diet impact was stronger in 
Figure 17 - Gene set enrichment score plot of unfolded protein response comparing GpatCD-HF and GpatHF-HF females. GpatCD-HF: HFD-fed offspring from grandfathers fed a chow diet; GpatHF-HF: HFD-fed offspring from grandfathers fed a HFD.Adapted from (Alm et al., 2017). 
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the liver than the skeletal muscle. In line with this, the liver exhibits gene sets affected solely 
by the grandpaternal high-fat diet. This is likely reflecting the plastic nature of the liver. A 
paternal low protein diet can affect the fatty acid metabolism in offspring livers (Carone et al., 
2010). Interestingly, we found that a grandpaternal high-fat diet altered genes associated to 
fatty acid metabolism. Since the fatty acid metabolism pathway is affected in two different 
animal models, by two different dietary interventions suggests that it is the site of epigenetic 
reprograming.    
 
Figure 18 - Significantly altered gene sets obtained by GSEA in the liver of F2 female rats from either chow- (GpatCD) or high-fat diet-fed (GpatHF) grandfathers. F2 rats were also subjected to either a chow (-CD) or high-fat diet (-HF). Gene sets with a negative normalized enrichment score (NES) are enriched in F2 females from GpatHF, while gene sets with a positive NES are enriched in F2 females from GpatCD. Dot sizes are scaled according to the percentage of core enriched genes in the respective gene set, and colored according to the F2 diet (black dot: chow diet and gray dot: high-fat diet). 
 
We chose to target the TNF-α signaling since it is closely related to metabolism and showed a 
grandpaternal-effect independent of the offspring’s own diet. RT-qPCR confirmed the gene 
array results. However, only one of the genes selected for the validation, G0s2 (G0/G1 Switch 
2), was found to be altered in a similar manner in the F1 liver. Next, we evaluated cytokine 
levels of the F2 livers. The grandpaternal high-fat diet reduced the level of TNF-α IL-5, IL-10, 
IL-13 and the granulocyte-macrophage colony-stimulating factor (GM-CSF) (Figure 19). 
TNF-α is a crucial adapter of chronic inflammation and is linked to both insulin resistance and 
obesity (Hotamisligil et al., 1993; Dandona et al., 1998). Animals with a GpatCD background 
exhibit a normal and expected increase of TNF-α by the high-fat diet. However, in animals 
with a GpatHF background the TNF-α response was blunted, suggesting that the GpatHF 
animals are not able to activate an appropriate inflammatory response. Furthermore, the 
expected increase of IL-5, IL-6, IL-10, IL-13 and GM-CSF weres also diminished in the 
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offspring with a grandfather on a high-fat diet. Together these results suggest that the TNF-α 
pathway is markedly affected by the grandpaternal diet.  
In both the liver and the skeletal muscle, we found several genes were altered by the 
grandpaternal high-fat diet in the F2 females, but not in the F1 generation. This indicates an 
alternative mechanism, in addition to the paternal gametic reprogramming that is regulating the 
transcriptomic response in these two tissues. One possible explanation is so called serial 
programming (Hur et al., 2017). In short, an intervention in the F0 causes one phenotype in the 
F1 that subsequently alters the epigenetic carrier and thereby causes a new phenotype in the 
F2. We utilized a paternal model of epigenetic inheritance and we did not observe a whole body 
phenotype in the male offspring. Thus, it is uncertain whether serial programing is causing a 
“skip” in the transcriptomic response. However, even though we did not observe a body weight 
or glucose tolerance phenotype in the male offspring, it is still possible that the paternal high-
fat diet caused a phenotype that we did not measure, and in turn could have caused this serial 
programming. In conclusion, our studies indicate that the gametic epigenome is amenable to 
dietary interventions and that it is able to adjust gene expression between generations. 
Additionally, variations in the ancestral diet seem to affect the transcriptome in the decedents 
in a tissue- specific manner and further influence the offspring response to its own diet. An 
interesting next step would be to combine the availed transcriptomic information and construct 
an atlas of genes that are responsive to ancestral diets. Although our ancestral dietary heritage 
can affect our metabolic health, it is important to recognize that our own lifestyle choices still 
triumph over our ancestors’.  
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Figure 19 - Abundance TNF-α, IL-5, IL-10, IL-13, GM-CSF and IL-6 in liver of GpatCD: grandpaternal chow; GpatHF: grandpaternal HFD; -CD: F2 chow; -HF: F2 HFD. *p≤ 0.05: GpatHF vs GpatCD; #p≤ 0.05: GpatHF-HF vs GpatCD-HF; ^p≤ 0.05: GpatCD-HF vs GpatCD-CD; &p≤ 0.05: GpatHF-HF vs GpatHF-CD; §p≤0.05: interaction effect. GpatCD: grandpaternal chow; GpatHF: grandpaternal HFD; -CD: F2 chow; -HF: F2 HFD. 
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5 SUMMARY AND CONCLUSIONS 
This thesis focuses on the role of environmental factors, exercise and grandpaternal diet, as 
factors that influence and regulate metabolism (Figure 20). It is well know that exercise is 
beneficial and is recommended for treatment and prevention of type 2 diabetes. Our results in 
study I clearly show that acute exercise causes an increased inflammatory response in the 
skeletal muscle of individuals with type 2 diabetes. However, it is unclear whether this is an 
adaptive or detrimental response. Thus, this area of research has ample room to increase its 
understanding of these complex processes. Further knowledge might prove to be key in 
developing treatments or a possible cure for metabolic disease.  
Additionally, our transgenerational studies (II-IV) provide further evidence on how ancestral 
lifestyle can lead to detrimental effects of environmental stressors in the future generations. We 
found that both the adipose tissue and liver transcriptome were affected by the grandpaternal 
high-fat diet, independent of the decedents own diet.  Although, worth noting, is that we did 
not observe a strong inter- or transgenerational dietary effect on whole body metabolism or 
skeletal muscle without introducing a further stressor, namely, a high-fat diet. Thus, our results 
highlight that the individual’s own lifestyle is still of great importance to their metabolic health.  
The specific conclusions of this thesis are: 
 Acute aerobic exercise induces an heightened inflammatory response in skeletal muscle 
of men diagnosed with type 2 diabetes.  
 
 Let-7c is a possible epigenetic molecular carrier underlying gametic inheritance of 
metabolic dysfunction.  
 
 A paternal/grandpaternal high-fat diet affects whole body metabolism of future 
generations. 
 
 Adipose tissue, skeletal muscle and liver are all susceptible genomic modifications 
induced transgenerationally by dietary factors. 
  
 46 
  
 
 
 
  
Fig
ure
 20 
– Su
mm
ary 
of t
he m
ain 
find
ing 
of t
his 
thes
is. E
nvir
onm
enta
l fac
tors
 dir
ectl
y in
flue
nce
 the
 me
tabo
lic h
ealt
h of
 the
 
exp
osed
 gen
erat
ion.
 Th
ese 
cha
nge
s ca
n be
 pas
sed 
dow
n th
roug
h a 
pate
rnal
 lina
ge v
ia th
e sp
erm
atoz
oa, 
pos
sibl
e th
roug
h th
e 
miR
NA
 Let
-7c,
 and
 aff
ect 
met
abo
lica
lly a
ctiv
e tis
sues
 and
 wh
ole-
bod
y m
etab
olis
m. T
he i
nsul
in r
esis
tant
 ske
leta
l mu
scle
 wil
l 
trigg
er a
 hei
ghte
ned
 infl
amm
ator
y re
spo
nse 
afte
r ex
erci
se.  
  47 
6 STUDY LIMITATION  
There are several limitations in the studies of this thesis, some of more practical nature and 
some more of an intrinsic. In study I our subjects had a smaller breakfast in the morning of the 
exercise bout (exercise and recovery biopsies), whereas they did not have this during the first 
biopsy (rest). Furthermore, there were 7-10 days in between the rest biopsy and the exercise 
and recovery biopsies. Both the smaller breakfast and the fact that all of the biopsies were not 
taken the same day could influence the results.  This was done for two main reasons. 1) We did 
not consider it ethical to take a muscle biopsy just before our upper middle-age unhealthy 
patients would perform a relatively tough bout of exercise or have them fasted for a total of 12-
14 hour. 2) Facilitate the recruitment of subjects. We wanted to avoid “intimidating” potential 
subjects away by using a too severe intervention. Although the minor breakfast could possible 
impact the result, it is not that likely. Our readouts were on a protein and RNA level, which are 
both not as sensitive as when measuring metabolites. Furthermore, both the control group and 
the type 2 diabetes group were subjected to the same protocol. Thereby, any co-founding effect 
that was added would be added to both groups and can therefore, to the most part, be ruled out.   
The biggest limitation of study II – IV is that it is performed in a rodent model. Not because 
that it is a rodent model, but because it is a model. If one is mainly working with models, may 
it be an animal or a cell model, it is easy to forget that it is merely a tool to understand human 
physiology. The big question is; how much of these results can be extrapolated to humans? 
Since rats and humans share around 80% of their protein coding DNA, it is fair to assume that 
the comparable (Fong et al., 2013). Thus, animal models is still a good, even crucial, resource 
for the scientific community to utilize. In additions, it makes it possible to investigate scientific 
questions that we could not otherwise do, due to ethical, logistical and financial reasons.  
Another limitation with study II – IV is the relatively low n number for the investigated 
adipose tissue, skeletal muscle and liver. In these three studies, we have utilized gene arrays to 
investigate the transcriptomic response to a grandpaternal high-fat diet. Omic’ methods are 
useful and powerful tools that are helping to increase gathered knowledge of the world. In our 
studies, we used them mainly as screening tools that was later validated using other univariable 
tools. Considering that the actually effect of the grandpaternal high-fat diet was mild, we would 
have greatly benefited by having a higher amount of (tissue) samples. This would have reduced 
the multiple comparisons problem and allowed us to more powerful bioinformatic tools, which 
could have given us more useful results.  
  
 48 
  
  49 
7 CLINICAL IMPLICATIONS 
Transferring basic research into clinic practice is a time consuming and usually not an easy 
process. As the cause with study I, we found that type 2 diabetic skeletal muscle responded 
with an increased inflammatory response. At a first glance, this imply that patients diagnosed 
with type 2 diabetes perhaps should use non-steroidal anti-inflammatory drugs to normalize 
their inflammatory response after exercising. However, since training has a proven beneficial 
effect in this population, it is likely that the training itself will normalize the inflammatory 
response. Furthermore, chronic drug use is almost always associated with negative side effects 
and should therefore, if possible, be avoided. Thus, our findings highlights the need for more 
studies before any recommendation can be given. 
We cannot influence the diet of our ancestors but we can affect our own. In study II – IV, we 
found that a grandpaternal high-fat diet has a negative impact on whole body metabolism and 
in specific tissues of future generations. However, on the bright side, the results are suggesting 
that the detrimental effect only occurs if the offspring is also subjected to an unfavorable diet. 
Thus, even if our parents or grandparents have been eating an unhealthy diet, this will not 
necessary have a negative impact on our metabolic health. Therefore, individuals and society 
should keep on promoting a balanced and healthy diet. We are not only eating for ourselves, 
but for our future generations’ metabolic health.    
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8 SVENSK POPULÄRVETENSKAPLIG SAMMANFATTNING 
Under de senaste decennierna har andelen överviktiga och feta ökat i en alarmerande hastighet 
och ökningen fortgår ännu. Detta leder till stora kostnader för samhället och ansenligt lidande 
för de drabbade individerna. Det mänskliga genomet har inte ändrats avsevärt under denna 
period. Det är snarare vår miljö och vårt sätt att leva som har ändrats. Våra arbeten är mycket 
mindre fysiskt krävande, vardaglig motion minskar och kaloririk mat har aldrig varit så lätt att 
få tag på som idag.  
Vikten utav fysiskaktivitet för ett hälsosamt leverne har varit känt sedan de gamla grekernas 
tid. Men även om detta har varit känt sedan länge, så är det oklart genom vilka mekanismer 
som fysisk aktivitet leder till positiva adaptioner. Dessutom vet vi inte hur, eller ens om, dessa 
mekanismer är förändrade vid metabola sjukdomar såsom typ 2 diabetes. Att ytterligare 
kartlägga den molekylära responsen av träning kan ge ny kunskap som kan bli avgörande i 
kampen för att behandla och förebygga metabol ohälsa.  
Utöver detta, så har det under senare år framkommit att förfäders livsstil kan påverka framtida 
generationer metabola hälsa. Dessa fynd visar att Lamarcks idéer om så kallad mjuk 
ärftlighethet är, åtminstone delvis, sanna. Däremot är det fortfarande inte klarlagt till vilken 
grad eller genom vilka mekanismer våra förfäders livsstil kan påverka oss idag. Att undersöka 
detta har varit ett av huvudsyfterna med denna avhandling.  
I studie I, har vi undersökt skelettmuskulaturens genuttryck efter en träningssession hos friska 
medelåldersmän samt män diagnostiserade med typ 2 diabetes. Vi fann att förändringar som 
kunde uppmätas efter 30 minuters cykel arbete var liknande mellan de två grupperna. Däremot 
skiljde sig diabetikernas respons tre timmar efter träningen avsevärt från kontrollgruppens. Hos 
typ 2 diabetiker var inflammationsresponsen  uppreglerad till en mycket högre grad. Vi kunde 
konfimera dessa fynd på såväl mRNA som på proteinnivå, och kunde visa genom mikroskopi 
att tre timmar efter träning fanns det en ökad mängd av vita blodceller i muskeln hos diabetiker 
I studie II, fick hanråttor äta en högfettsdiet under 10 veckor innan de parades med honor som 
hade ätit vanligt foder. Avkomman till dessa råttor (F1 generationen) fick antingen äta 
högfettsdiet eller vanligt foder. De hanar i F1-generationen som hade ätit en vanlig foder-diet 
användes för att generera F2-generationen. Delar av F1 och F2-avkomman tilldelades även en 
högfettsdiet. Vi fann att honor från en högfettsdiet-fader/farfar inte ökade i vikt till samma grad 
som honor med en far/farfar på en vanlig foder-diet, när de själva åt en högfettsdiet. De var 
med andra ord skyddade från den förväntade viktuppgången av högfettsdieten. Trots detta var 
deras glukostolerans till och med lite försämrad. Således hade deras farfars kost påverkat hur 
de svarade på olika sorters kost. För att hitta en möjlig mekanism som kan förklara hur farfaders 
kost kan ändra det metabola svaret två generationer senare så sekvenserade vi RNA från 
spermierna från den första generationen. Vi fann förändringar i antal av små, och kodande RNA 
(micorRNA). Speciellt fann vi evidens för att microRNA:t Let-7c kan vara en möjlig 
epigenetisk bärare av det kostbaserade fädernearvet.  
 52 
I studie III och IV, utvärderade vi vävnadspecifika skillnader i fram för all skelettmuskelatur 
och lever från djuren i studie II. I båda studierna undersökte vi initialt det globala genutrycket 
från vävnaderna med så kallade gene arrays. I studie III fann vi att att ”unfolded protein 
response” var uppreglerad i skelettmuskelaturen från F2 honor med en farfar som hade ätit en 
högfettsdiet, när det själva åt en högfettsdiet. I studie IV, fann vi att farfädernas högfettdiet 
förändrade TNF-α signaleringen i lever, oberoende av avkommans egna diet. 
Tillsammans visar dessa studier hur, och genom vilka möjliga mekanismer, miljön (både den 
vi ärvt och den vi utsätts för direkt) kan påverka vår metabolism och metabola hälsa.  
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9 POPULÄRVETENSKAPLIG SAMMANFATTNING PÅ PITMÅLE 
Sisstå:ra jena håva döm som väga för mötche å döm som våra fääit euöke falit fort, å hä fortsätt 
åt euök änn. Hä djär:r åt hä kosst möche för samhälle å döm som våre drabbe fåra iill. Jenå:me 
öte fåLke hav et endrese jusst na: under den här tijdn. Hä jär mässte miljön:n å sätte vä leva 
opa som jär endre. Jobba våre våra minnder taång, man rö:r sä minnder, å fäijtma:tn hav åller 
vöre så jett åt få ta:g i som nöförtijdn. 
Man har lèeng, ja redan i Grekland veta omm, vöre viktigt hä jär åt rö:r opa: sä om man vell 
leva hällsosamt. Men fastann hä hav vöre tjennt, hav man et fåta vo hä jär för mekanissmom 
som djär:r åt ge:nen förendres del na bätter. Vä veta et hälar vöre, älär ensch hur de dära 
mekanisma våra förendre bårte ämnesommsättningsschu:kdaåma, som dell exämpäL typ-to: 
sokkerschu:ka. Åt man ännu mäijr undersch:ök molekylä:r-reakschåon som vàaL bårt hä man 
trään, kan vàaL mötche vikitit då hä djäll åt arrbaijt måt ämnesomsättningsschu:kdaåoma.  
Mäijr än dòoj, have opa sisså:ra vorte tjennt åt vöre gambLen förr i ti:jdn lèevd kan innvärk 
opa vöre jeneraschaåna lenger framm å ämnesommsättninga dömersch. Hä hav bevijse åt hä 
n´Lamarck ment om ”mju:k ärftlighäijt”, åtminnschtone däijlvijs jär sannt. Däremaåot jär e et 
änn riktit kLart vöre mötche älär djuning vo mekanissmom gameLfåLkes sätt åt leva kan 
på:värk åss ida:. Åt skoda hä: hav vöre na: båRte de viktigaste vä avhandlingen jena. 
Öte förschtstu:dien håva vä underschökt jenå:me borte skelättmusskulateurn öte frijska/kroija 
håLvgamLa karom, å nest karan som håva ’ty:p to:sokkerschu:ka, äätt ha döm håva tre:ne, vä 
mäRt åt förscht reakschaån var gaåde li:jk mila bå: gruppa, men åt sokkerschu:kgruppen äätt 
to: ti:jmsthilld sä mötche frå kontrollgruppen. Dömärsch infLammaschaånsschwa:r var 
oppreglä:re mötche mäijr. De resultata konfirmä:reses seda opa protein:nnivå me to: andre 
metoder. 
Öte andra stu:dien gåv vä matn vä mötch fäijta åt ha:nrotten i ti: vecko, öte döm pa:re sä vä 
ho:nen, som hadd ite vannlit faåor. Ha:na båRte F1-generaschaån, som hadd ite vannlit faår, 
anvendese del åt jenrär F2-generaschaåon. Nager båRte F1- och F2- aåonga feng åkksa en 
hö:gfäijtsdiet. Vä sååg åt ho:nen ät ”högfäijtspapp-älär-farfar” inte euöke leka mötche i vekt, 
som hon:nen vä ’n papp/farfar vä vannlit faåor ,då döm schöölv åt hö:fäijtsdietn. Döm vaår 
alltså som ”vaksinä:re” frå åt vàaL så fäijt som döm sku håva böt bLi:j. Ennda var 
gLukå:stoleranschn dömersch del å mä:ngen nallta försemmre. Jams anne, fonn vä åt 
microRNA:t Let-7c som en måjli epijene:tisk bärar å ma:tarve opa fa:rsch-sijda. 
Öte tredje- å fjö:Lstu:dien, jämfo:L vä stjilnèen öte särschilda vävnadom, bäinrangeL-
muskulateurn å levra, bårte dju:ra öte àannstu:dien. B`åå: gangen underschökt vä förscht ”de 
gLoba:la jen-auttrökke” frå vä:vnada vä hä som kå:les ”gene arrays”. Vä hitte öte tredje 
stu:dien åt ”unfolded protein response” var oppreglä:re ine bäinrangeL-muskulateurn bårte 
F2-ho:nen vä ’n farfar som hadd ite en hö:gfäijtsdie:t, jämföRt vä ho:nen vä ’n farfar:r vä vannli 
foderdie:t, då döm schölLv åå:t ’n högfäijtsdie:t. Öte fjö:Lstu:dien, så:g vä, åt farfa:ras 
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hö:gfäijtsdie:t förendre TNF-α signaleringen, vöre änn aåonga schö:lv `ååt.  
Ållt häijn, ihaåoptåje, vi:js stu:dien jena vöre å djuning vo måjliga mekanismom, miljö:n kan 
på:värk ämnesommsättningen våre å hä som hav vä töker schukdaåomom åt djära. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Texttolkning: 
Understrykning är en markering för kortstavighet. Kolon (:) efter en bokstav visar att ljudet är 
långt. Versalt L, är ett tecken som visar att det uttalas med "tungslag"som i svenskans "pärla". 
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